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ABSTRACT
Automating aspects of biocuration through biomedical information ex-
traction could significantly impact biomedical research by enabling greater
biocuration throughput and improving the feasibility of a wider scope. An
important step in biomedical information extraction systems is named entity
recognition (NER), where mentions of entities such as proteins and diseases are
located within natural-language text and their semantic type is determined.
This step is critical for later tasks in an information extraction pipeline, in-
cluding normalization and relationship extraction.
BANNER is a benchmark biomedical NER system using linear-chain
conditional random fields and the rich feature set approach. A case study with
BANNER locating genes and proteins in biomedical literature is described.
The first corpus for disease NER adequate for use as training data is intro-
duced, and employed in a case study of disease NER. The first corpus locating
adverse drug reactions (ADRs) in user posts to a health-related social website
is also described, and a system to locate and identify ADRs in social media
text is created and evaluated.
The rich feature set approach to creating NER feature sets is argued
to be subject to diminishing returns, implying that additional improvements
may require more sophisticated methods for creating the feature set. This
motivates the first application of multivariate feature selection with filters
and false discovery rate analysis to biomedical NER, resulting in a feature
set at least 3 orders of magnitude smaller than the set created by the rich
feature set approach. Finally, two novel approaches to NER by modeling the
semantics of token sequences are introduced. The first method focuses on the
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sequence content by using language models to determine whether a sequence
resembles entries in a lexicon of entity names or text from an unlabeled corpus
more closely. The second method models the distributional semantics of token
sequences, determining the similarity between a potential mention and the
token sequences from the training data by analyzing the contexts where each
sequence appears in a large unlabeled corpus. The second method is shown to
improve the performance of BANNER on multiple data sets.
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Chapter 1
INTRODUCTION
Like many modern sciences, the primary constraint in advancing the
biological sciences is moving away from gathering data to evaluate
hypotheses and instead towards the data interpretation and theory creation
necessary to make sense of large amounts of data. This trend has driven an
increasing recognition of the importance of biocuration - the field that
organizes the results of biomedical research and makes them available
[12, 56]. While this increased recognition has driven an increase in the rate of
biocuration, research continues at a much faster rate than biocuration can
handle [6]. As a result, the potential of existing research to enable further
discoveries is not being fully realized.
One possibility for increasing the rate of biocuration is with natural
language processing (NLP) techniques [1, 55, 92]. Biomedical information
extraction is a sub-field of biomedical NLP that seeks to locate, categorize,
and extract information from various biomedical texts, including scientific
articles, in support of tasks such as biocuration, and patient records, for
tasks such as clinical decision support [30].
While increasing the rate of biocuration is an important goal, another
significant application of biomedical natural language processing techniques
is enabling the extraction of information that would otherwise not be
available. One example is mining text authored by patients for information
relating to their health. The large volume of text in most social media, where
such text can be found, implies the necessity of automated techniques.
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1.1 Overview of Information Extraction
Biomedical information extraction systems are typically designed as
pipelines, with each module in the pipeline performing a specific processing
task. Some tasks are relatively straightforward and typically handled by
deterministic techniques. These include sentence segmentation and
tokenization (breaking text into individual word-like units). Other tasks
involve more nuanced decision making and frequently utilize machine
learning, typically supervised classification. In a typical biomedical
information extraction pipeline, the first task encountered that may require
advanced techniques is named entity recognition (NER). NER is the task of
locating mentions of entities in natural language text, specifying both the
span - start and end position - and semantic type [74].
While many methods have been used for biomedical NER, the
state-of-the-art generally involves tokenization as a preprocessing step,
followed by labeling with a supervised sequence classification model using a
rich feature set [69, 100]. Rich feature sets describe a wide variety of different
aspects of each token, including prefixes and suffixes, word stems or lemmas,
part of speech, and so on [100]. These features are typically binary-valued; an
example would be whether the current token ends in -ase. However, in the
rich feature set approach the NER system developer typically does not create
individual features. Instead, developers create feature extraction templates,
such as the last three characters of each token. These are then instantiated
into binary features using the actual values seen in the training data.
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1.2 Problem Background
The rich feature set approach has been successfully applied to find many
entity types, including genes, proteins, RNA, cell lines and cell type [100],
genomic variations [79], drug names [64], and diseases [34, 70]. A critical
advantage of the rich feature set approach is the ability to adapt the feature
set to the dataset used. The rich feature approach introduces several
difficulties, however, that result in diminishing returns as the feature set is
developed. This chapter argues that the feature extraction methods used to
create rich feature sets for biomedical named entity recognition have become
a constraint for improved performance. This discussion is motivated through
an analysis of several qualities that contribute to system performance and
how the rich feature set approach affects each.
A system is said to generalize well if it performs well on previously
unseen data [2]. The distributions of the frequency that specific words
appear in a text approximates a power law, a result known as Zipf's law
[77, 128]. According to Zipf's law, the frequency a word appears in a large
segment of text is inversely proportional to the rank of its frequency. This
implies a long tail effect where a few words appear frequently, some words
have medium frequency, but most words are rare. Many of the tokens in the
unseen text have therefore not been seen in the training data. Since the
features are extracted from the training data, the model therefore only
contain a few features usable for inference on these tokens, which increases
overfitting and reduces the generalization of the model.
A system is stable if small variations in the training data produce
models with low levels of disagreement when applied to the same text [101].
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Zipf's law also implies that most words present in the training data appear
only a few times, causing most of the features to have a highly skewed ratio
between the number of times the feature is active and inactive. This
imbalance causes the correlations of the features with the class to be sensitive
to small perturbations in the training data, thereby reducing model stability.
A system is robust if the performance declines gracefully with the
introduction of noise [39]. For NER, the training data is manually created
and is difficult to keep consistent [1], making it a significant source of noise.
However, because categorical variables are represented in the feature set as
many boolean features with only one feature with the value true - the
one-hot representation - inactive features are relatively uninformative for
classification in rich feature sets, and only a very small percentage of the
features in the set will be active for any given token. The model is therefore
forced to classify each token using whatever features happen to be active,
some of which are not stable. This reduces robustness by increasing the
model sensitivity to any inconsistencies in the training data.
A system has higher learning efficiency if it achieves higher
performance given the same amount of training data [124]. High learning
efficiency is particularly important when only a small amount of data is
available, but is always a concern because of the high expense of annotating
new corpora to obtain training data. Training data is required to estimate
the relevance of each feature, so that learning efficiency is reduced as the
number of features increases. Unfortunately, rich feature sets typically reach
extremely high dimensionality since the features are derived from the words
in the training set, and most of the words are rare. It is common for
state-of-the-art biomedical NER systems to use hundreds of thousands or
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even millions of features. In such a large feature set, many of the correlations
between the features and the class are likely due to chance [90], a problem
known in statistics as multiple comparisons [60].
The portability of a system concerns the amount of new development
required to obtain quality results in a different corpus or domain. Porting an
existing biomedical NER system to recognize mentions of a new entity type
usually requires analysis to identify new feature templates. Entity mentions
frequently exhibit a meaning that is not entirely compositional, similar to
collocations [77]. In other words, the meaning of the sequence of tokens that
comprise the name - in this case, whether the sequence refers to an entity of
a specified type - is richer than the union of the meanings of each constituent
token. Unfortunately, the sequence classification models typically in use in
biomedical named entity recognition can only model sequence features that
can be decomposed by the Markov assumption [98]. Since this
extra-compositional meaning cannot be modeled directly, the model must
compensate by relying more on indirect clues such as features from manually
engineered templates, thus decreasing the portability.
1.3 Overall Goal
The primary goal of this dissertation is to improve biomedical named entity
recognition (NER). This improvement is accomplished through two
complementary approaches, based on the premise that the rich feature
representation currently used in state-of-the art biomedical NER is subject
to diminishing returns. The first approach uses advanced feature selection
techniques to determine the relevance of each feature extracted and remove
features that prove uninformative. The second approach introduces
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sophisticated new features to model the meaning of the token sequences more
closely than the existing binary features.
1.4 Contributions
There are several innovate aspects of this work. Distributional semantics has
been shown to be useful for improving NER [61, 115]. However all techniques
used to date are based on single tokens, even though entity names exhibit
non-compositional meanings. This motivates the first distributional
semantics technique for modeling the semantics of token sequences in the
context of NER, rather than individual tokens.
Biomedical NER systems have been shown to not always benefit when
features derived from a list of entity names (a dictionary) were used [100].
Processing the name list to only contain highly indicative tokens was able to
show an improvement [50], an approach that has been both automated and
strengthened theoretically by incorporating language modeling of both the
entity names and general biomedical text.
Previous work applying feature selection to biomedical NER used the
χ2 test, a standard statistical hypothesis test, and information gain, an
information-theoretic criterion [62]. Since NER features are highly
imbalanced, however, χ2 tests are not appropriate for determining feature
significance [35, 91]. While much of the literature on feature selection
assumes that feature redundancy is detrimental, more recent work shows
through theoretical and empirical analysis that this is not accurate [13]. Rich
feature sets exhibit a very high degree of redundancy since they are generated
by applying many interdependent extraction templates to the training data.
The application of feature selection therefore employs a filter based feature
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selection algorithm which considers feature redundancy, resulting in the first
application of joint mutual information to biomedical NER.
The false discovery rate (FDR) - roughly the percentage of the
features accepted as relevant which are actually irrelevant - has been shown
to be a useful criterion for determining a stopping threshold for feature
selection [45]. The first FDR analysis of a feature selection algorithm in the
context of biomedical NER is performed.
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Chapter 2
FUNDAMENTALS
Biomedical information extraction systems typically use the pipeline
architecture, with biomedical NER used as a building block step for higher
level information extraction tasks including entity identification and relation
extraction. NER is therefore a critical task for biomedical information
extraction from biomedical texts and for most forms of natural language
processing. While there has been significant work to solve NER, performance
for NER systems in the biomedical domain is still significantly lower than
human performance. The primary goal is to identify the remaining challenges
and propose new work to resolve them.
2.1 Information Extraction
Natural language processing of biomedical articles has received significant
attention. Much of the work has been driven by academic challenges such as
BioCreative and the BioNLP shared tasks [3, 72, 104]. Many of these tasks
have concentrated on applications of biomedical information extraction,
particularly entity identification, protein-protein interaction extraction and
event detection.
2.2 Named Entity Recognition
In named entity recognition (NER), the task is to locate the entities
referenced in natural language text, and determine the semantic type of each.
Each reference to an entity is called a mention. An NER task in the
newswire domain might require the location of mentions referring to people,
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places and organizations. NER in the biomedical domain typically involves
semantic types such as proteins, genes, diseases, organisms, and drugs.
Biomedical NER is a particularly difficult problem for several reasons:
1. There are many semantic types of interest to researchers; the UMLS
Metathesaurus, for example, contains 135 different semantic types [87].
2. There are many names used in the literature. For example, there are
millions of gene names in actual usage [104]. Many entities have several
names in actual usage. This is partly because authors often prefer to
use a name of their own invention rather than an official or
standardized name for the entities their writing refers to [36].
3. Names are often ambiguous. This is especially a problem with
acronyms [74]. Thus the correct semantic type often must be inferred
from context even if the name itself is recognized. HD for example,
could refer to either Huntington disease or the gene whose mutated
form causes it [70].
4. Many semantic types are easily confused with each other due to similar
vocabulary or context. For example, trained human annotators cannot
always distinguish between genes and proteins [110]. In fact, whether
an entity should be considered a separate type or not depends on the
purpose of the task.
2.3 Techniques for Named Entity Recognition
Methods for NER fall into three primary categories [74]; each category is
surveyed in this section. The first method considered is the so-called
dictionary approach, where a list of entity names is used to locate the
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entities in biomedical natural language text. Typically some processing is
performed, such as case normalization or handling of variant terms or
transformations that are specific to the entity type. For example, a lower
case h at the beginning of a gene name indicates that the mention refers to
the gene as found in humans. Dictionary methods have the advantage of
immediately providing a potential identification of the entity being
referenced by the mention. On the other hand, they have the disadvantage of
requiring a comprehensive name list that is not available for all entity types
of interest. It can also be difficult to create the set of string transformations
that represent valid variations of the names. Despite these difficulties,
dictionary methods for NER enjoy widespread support.
A second common method is the rule based approach, where a set of
patterns - frequently based on regular expressions - is applied to locate
entities of the specified type. This approach has the advantage of not
requiring a comprehensive listing of entity names. It has the additional
advantage of providing an explanation for the decisions it makes; the rule
that triggered the decision can be used to show the user why the decision
was made. The primary disadvantage of this approach is the significant
investment required to create the rules. In addition, these rules have been
found to not generalize well: performance drops significantly when applied to
text with slightly different characteristics.
A third approach is the use of machine learning in the form of
supervised classification. Early approaches used instance classifiers such as
naïve bayes or support vector machines to predict the label for a given token
[74]. Later work introduced sequence classification models including hidden
Markov models (HMMs) and maximum entropy Markov models (MEMMs),
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which learn a mapping from an input sequence to a sequence of output labels
[11, 23]. Unlike HMMs, MEMMs are discriminative models and therefore do
not assume independence between the features. This allows NER system
developers to utilize virtually any feature they believe may be useful.
However, this strong advantage of discriminative models is partially negated
by the dependence on the training data introduced by limiting the feature set
to the values observed there.
Many systems employ some form of hybrid between the three
techniques. As an example, a recent work used a combination of linguistic
rules and a large number of dictionaries to assign a broad semantic class to a
large number of potentially overlapping semantic classes [20].
2.4 Machine Learning Methods for NER
NER systems employing classification must choose a set of labels to
differentiate between mentions of different types and non-mention text [102].
The simplest method uses one label (O) for non-mention tokens, and
another label (e.g. I-Protein or I-Drug) for each entity type in the
training data, however this label set cannot differentiate between adjacent
entities of the same type. While this condition is actually rare [37], many
systems report a performance increase by employing a different label (B)
for the first token in a mention.
2.4.1 Rich Feature Sets
All machine learning systems receive their input about a learning task via
the set of features used. These features are critically important, as the
learning algorithm will be blind to any information they do not provide.
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Each feature must be encoded into the representation required by the
machine learning component. For most machine learning systems, features
are encoded as a vector of numeric values which, for convenience, are often
indexed by labels representing the meaning of the feature. For example, a
label could be token='gene', indicating that the token is the word gene, and
the value would be binary, with 0 representing false and 1 representing true.
For NER, each input text - typically a single sentence - is represented by a
sequence of feature vectors.
Current state-of-the-art systems for biomedical NER typically utilize a
rich feature set with a size in the hundreds of thousands [69, 100]. This often
results in more features than points of training data, a condition known as a
wide dataset. Most biomedical NER systems therefore use regularization to
control overfitting. Regularization introduces a penalty on large parameters
in an attempt to keep the weight of a few parameters from overwhelming the
remainder. The most common form of regularization used in biomedical NER
systems appears to be L2 regularization, which drives the parameters for
irrelevant features towards zero asymptotically. Other forms of regularization
are also possible, notably L1 regularization, which results in a sparse solution
since the parameters for useless features are driven to exactly zero [68, 89].
For example, the system developer may create a template that
instantiates a feature from each of the suffixes of length 3 seen in the training
data. Some of these features will be informative - for example, tokens that
end in the suffix -ase are frequently names of enzymes, a kind of protein -
while many features will be marginal or irrelevant. The resulting features are
typically encoded using the one-hot representation, where only one of the
features generated by a template, such as suffix=ase, will be active (have
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the value true) and all others will be inactive (have the value false).
Achieving the highest possible performance on a new dataset requires
significant new development to engineer new feature templates. One example
from a work to recognize chemical names in text is the inclusion of features
representing the single characters before and after the current token [64].
2.4.2 Conditional Random Fields
Much of the recent work in biomedical NER has centered on a discriminative
sequence classifier, linear-chain conditional random fields [67, 79]. Unlike
MEMMs, conditional random fields (CRFs) are normalized per sequence
rather than per tag, avoiding the so-called label bias. While conditional
random fields can, in general, take the form of an arbitrary graph, the form
most often used in natural language processing is linear-chain, where the
nodes are arranged in a sequences and only connected to adjacent nodes.
Following the notation in [63], the equations for conditional random
fields are:
p−→
λ
(−→y |−→x ) = 1
Z−→
λ
(−→x ) · exp
 n∑
j=1
m∑
i=1
λifi(yj−1, yj,−→x , j)

Z−→
λ
(−→x ) = ∑
−→y ∈Y(m)
exp
 n∑
j=1
m∑
i=1
λifi(yj−1, yj,−→x , j)

Where:
• −→x is the input sequence
• −→y is the sequence of output labels
• n = |−→x | = |−→y |
• −→λ are the feature weights
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• f are the feature functions
• m = |−→λ | = |f |
• Y is the set of possible labelings
The time complexity for training and inference for linear-chain
conditional random fields are as follows:
• O(tks2n), for training
• O(s2n), for inference
Where:
• t is the number of training instances
• s is the number of states
• k is the number of training iterations performed
• n is the length of the instance
2.5 NER System Evaluation
Biomedical NER systems are typically evaluated in terms of precision (p)
and recall (r), which is then frequently summarized in the F1 measure (f).
These are defined as follows:
p = tp
tp+ fp, r =
tp
tp+ fn, F1 =
2pr
p+ r
Where:
• tp is the number of true positives
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• fp is the number of false positives
• fn is the number of false negatives
These definitions do not specify, however, what constitutes a true
positive, false positive and false negative. In NER these definitions are not
always straightforward, since it is arguably better for a system to find most
of the span of a mention than to not mark it at all or perhaps to mark a
mention with a slightly incorrect semantic type rather than to miss it
completely. This leads to many possibilities in how to consider a match
correct, however the most common evaluation measure is what is known as
exact match [41]. Exact match requires that the left boundary, the right
boundary and the semantic type all match exactly for a true positive to be
counted. Any mention returned by the system which is not a true positive is
counted as a false positive, and any mention required by the evaluation data
which does not have a corresponding true positive is considered a false
negative.
2.6 Corpora for NER Training and Evaluation
Modeling biomedical NER as a supervised learning problem implies that
training data will be needed in addition to data for evaluation. Several
biomedical NER corpora are available for training and evaluation. These
corpora are annotated for different semantic types, and represent different
degrees of size and quality.
The BioCreative 2 Gene Mention corpus contains sentences from
biomedical abstracts annotated with genes and proteins as a single semantic
type. This corpus also contains alternate annotations; the scoring for this
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corpus is therefore modified so that any one of the alternate annotations is
considered a true positive. The NCBI Disease Corpus contains complete
biomedical abstracts annotated for disease mentions. This corpus is derived
from previous work for disease mentions by the author [70]. The BioCreative
2 Gene Mention and NCBI Disease corpora form the core of the evaluation in
this work. There are many other corpora, however. One interesting recent
corpus is the CALBC corpus, which was created by harmonizing the
annotations of multiple automated systems [48]. Because this corpus was not
created by human annotators, it is called a silver standard corpus. The
advantage of a silver standard corpus, however, is the feasibility of providing
much more data than may be provided by human annotators.
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Chapter 3
CASE STUDY: GENES AND PROTEINS
This chapter describes a case study in biomedical named entity recognition,
locating genes, proteins, and diseases. This work resulted in the creation of
BANNER, a trainable biomedical NER system based on conditional random
fields a rich feature set.
3.1 Background
BANNER is an open source biomedical named entity recognition system
implemented in Java, serving as an executable survey of advances [69].
BANNER based on conditional random fields using the rich feature set
approach. BANNER implements a wide range of orthographic,
morphological, and shallow syntax features, including the part of speech,
lemma, n-grams, prefixes, and suffixes. A primary design constraint for
BANNER is configurability: BANNER is intended to enable experimental
evaluation of a variety of different configurations, including the label model
and the order. The initial version of BANNER did not include a feature
based on lists of entity names, but did include two forms of postprocessing.
The first form of postprocessing detects when only one of a pair of
parentheses was tagged in the output. The second form of postprocessing is
detection of a long form, short form pair, such as antilymphocyte globulin
(ALG) [99].
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Figure 3.1: The architecture of BANNER.
3.2 Methods
BANNER is designed as a processing pipeline. Input text is first broken into
sentences, and is then tokenized. BANNER uses a tokenization strategy that
is both straightforward and highly consistent. Tokens are broken at all white
space and at punctuation. The tokens returned therefore consist of
contiguous alphanumeric sequences or a single punctuation mark.
A series of experiments is performed to determine the
highest-performing configuration of BANNER for the BioCreative 2 Gene
Mention data set. The configuration using a 2nd order CRF, the IOB label
model, using parenthesis post-processing, and not splitting tokens at
letter/digit boundaries were the best performing configuration elements. A
series of experiments to manually select feature templates are performed,
where it was found that adding part of speech tags, lemmas, and numeric
normalization all improved performance.
The BANNER architecture is a 3-stage pipeline, illustrated in Figure
3.1. Input is taken one sentence at a time and separated into tokens,
contiguous units of meaningful text roughly analogous to words. The stream
of tokens is converted to features, each of which is a name/value pair for use
18
by the machine learning algorithm. The set of features encapsulates all of the
information about the token the system believes is relevant to whether or not
it belongs to a mention. The stream of features is then labeled so that each
token is given exactly one label, which is then output.
The tokenization of biomedical text is not trivial and affects what can
be considered a mention since generally only whole tokens are labeled in the
output [125]. Unfortunately, tokenization details are often not provided in
the biomedical named entity recognition literature. BANNER uses a simple
tokenization which breaks tokens into either a contiguous block of letters
and/or digits or a single punctuation mark. For example, the string
Bub2p-dependent is split into 3 tokens: Bub2p, -, and dependent.
While this simple tokenization generates a greater number of tokens than a
more compact representation would, it has the advantage of being highly
consistent.
BANNER uses the CRF implementation of the MALLET toolkit [78]
for both feature generation and labeling using a second order CRF. The set
of machine learning features used primarily consist of orthographic,
morphological and shallow syntax features. While many systems use some
form of stemming, BANNER instead employs lemmatization [119], which is
similar in purpose except that words are converted into their base form
instead of simply removing the suffix.
Another notable feature is the numeric normalization feature [112],
which replaces the digits in each token with a representative digit (e.g. 0).
Numeric normalization is useful since entity names often occur in series, such
as the gene names Freac1, Freac2, etc. The numeric-normalized value for all
these names is Freac0, so that forms not seen in the training data have the
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same representation as forms which are seen. The entire set of features is
used in conjunction with a token window of 2 to provide context, that is, the
features for each token include the features for the previous two tokens and
the following two tokens.
There are features discussed in the literature which are not
implemented in BANNER, particularly semantic features such as a match to
a dictionary of names and deep syntactic features, such as information
derived from a full parse of each sentence. Semantic features generally have a
positive impact on overall performance [125] but often have a deleterious
effect on recognizing entities not in the dictionary [100, 127]. Moreover,
employing a dictionary reduces the flexibility of the system to be adapted to
other entity types, since comparable performance will only be achieved after
the creation of a comparable dictionary. While such application-specific
performance increases are not the purpose of a system such as BANNER,
this is an excellent example of an adaptation which researchers may easily
perform to improve BANNER`s performance for a specific domain.
Deep syntactic features are derived from a full parse of the sentence,
which is a noisy and resource-intensive operation with no guarantee that the
extra information derived will outweigh the additional errors generated [74].
The use of deep syntactic features in biomedical named entity recognition
systems is not currently common, though they have been used successfully.
One example is the system submitted by Vlachos to BioCreative 2 [119],
where features derived from a full syntactic parse boosted the overall F-score
by 0.51.
There are, however, two types of general post-processing which have
good support in the literature and are sufficiently generic to be applicable to
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any biomedical text. The first of these is detecting when matching
parentheses, brackets or double quotation marks receive different labels [32].
Since these punctuation marks are always paired, detecting this situation is
useful because it clearly demonstrates that the labeling engine has made a
mistake. BANNER implements this form of processing by dropping any
mention which contains mismatched parentheses, brackets or double
quotation marks. The second type of generally-applicable post-processing is
called abbreviation resolution [127]. Authors of biomedical articles often
introduce an abbreviation for an entity by using a format similar to
antilymphocyte globulin (ALG) or ALG (antilymphocyte globulin). This
format can be detected with a high degree of accuracy by a simple algorithm
[99], which then triggers additional processing to ensure that both mentions
are recognized.
3.3 Comparison
BANNER was evaluated with respect to the training corpus for the
BioCreative 2 GM task, which contains 15,000 sentences from MEDLINE
abstracts and mentions over 18,000 entities. The evaluation was performed
by comparing the system output to the human-annotated corpus in terms of
the precision (p), recall (r) and their harmonic mean, the F-measure (F).
These are based on the number of true positives (TP), false positives (FP)
and false negative (FN) returned by the system:
The entities in the BioCreative 2 GM corpus are annotated at the
individual character level, and approximately 56% of the mentions have at
least one alternate mention annotated, and mentions are considered a true
positive if they exactly match either the main annotation or any of the
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alternates. The evaluation of BANNER was performed using 5x2
cross-validation, which Dietterich shows to be more powerful than the more
common 10-fold cross validation [31]. Differences in the performance reported
are therefore more likely to be due to a real difference in the performance of
the two systems rather than a chance favorable splitting of the data.
The initial implementation of BANNER included only a naïve
tokenization which always split tokens at letter/digit boundaries and
employed a 1st-order CRF. This implementation was improved by changing
the tokenization to not split tokens at the letter/digit boundaries, changing
the CRF order to 2, implementing parenthesis post-processing and adding
lemmatization, part-of-speech and numeric normalization features. Note that
both the initial and final implementations employed the IOB label model.
Table 3.1 presents evaluation results for the initial and final implementations,
as well as several system variants created by removing a single improvement
from the final implementation.
The only system variant which had similar overall performance was
the IO model, due to an increase in recall. This setting was not retained in
the final implementation, however, due to the fact that the IO model cannot
distinguish between adjacent entities. All other modifications result in
decreased overall performance, demonstrating that each of the improvements
employed in the final implementation contributes positively to the overall
performance.
The performance of BANNER was compared against the existing
freely-available systems in use, namely ABNER [100]. The evaluations are
performed using 5x2 cross validation using the BioCreative 2 GM task
training corpus, and reported in Table 3.2.
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BANNER System Variant Precision Recall F-measure
Initial implementation 0.8239 0.7621 0.7918
Final implementation 0.8509 0.7906 0.8196
With IO model instead of IOB 0.8471 0.7940 0.8196
Without numeric normalization 0.8456 0.7909 0.8174
With IOBEW model instead of IOB 0.8546 0.7815 0.8164
Without parenthesis post-processing 0.8509 0.7906 0.8196
Using 1st order CRF instead of 2nd or-
der
0.8449 0.7872 0.8150
With splitting tokens between letters
and digits
0.8454 0.7835 0.8133
Without lemmatization 0.8444 0.7800 0.8109
Without part-of-speech tagging 0.8402 0.7783 0.8081
Table 3.1: Results of evaluating the initial version of BANNER, the final
version, and several system variants created by removing a single improvement
from the final implementation.
System Precision Recall F-measure
BANNER 0.8509 0.7906 0.8196
ABNER 0.8312 0.7394 0.7830
Table 3.2: Results of comparing BANNER against existing freely-available
software, using 5x2 cross-validation on the BioCreative 2 GM task training
corpus.
To demonstrate portability, another experiment is performed using
5x2 cross validation on the disease mentions of the BioText disease-treatment
corpus [94]. These results are reported in table 3.3. The relatively low
performance of all three systems on the BioText corpus is likely due to the
small size (3655 sentences) and the fact that no alternate mentions are
provided.
Like BANNER, ABNER is also based on conditional random fields;
however it uses a 1st-order model and employs a feature set which lacks
part-of-speech, lemmatization and numeric normalization features. In
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System Precision Recall F-measure
BANNER 0.6889 0.4555 0.5484
ABNER 0.6608 0.4486 0.5344
Table 3.3: Results of comparing BANNER against existing freely-available
software, using 5x2 cross-validation on the disease mentions from the BioText
corpus.
System or Author Rank at
BioCreative 2
Precision Recall F-measure
Ando 1 0.8848 0.8597 0.8721
Vlachos 9 0.8628 0.7966 0.8284
BANNER - 0.8718 0.8278 0.8492
Baumgartner et. al. 11 (median) 0.8554 0.7683 0.8095
NERBio 13 0.9267 0.6891 0.7905
Table 3.4: Comparison of BANNER to selected BioCreative 2 systems [104].
addition, it does not employ any form of post-processing, though it does use
the same IOB label model. ABNER employs a more sophisticated
tokenization than BANNER, however this tokenization is incorrect for 5.3%
of the mentions in the BioCreative 2 GM task training corpus.
The large number of systems (21) which participated in the
BioCreative 2 GM task in October of 2006 provides a good basis for
comparing BANNER to the state of the art in biomedical named entity
recognition. These results are reported in Table 3.4.
The performance of the BANNER named entity recognition system
was later increased by 1.4% f-measure on the BioCreative 2 Gene Mention
set by adding a list of single tokens highly indicative of a gene name being
present [50]. This list was derived by extracting all of the single tokens from
the gene and protein names in EntrezGene, UniProt, HUGO and the
BioCreative 2 Gene Normalization training set. Tokens more likely to appear
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outside of an entity mention than inside of an entity mention in the training
data for the BioCreative 2 Gene Mention training data were then removed.
The list is used as a binary feature, with tokens on the list (case-insensitive)
given the value 1, and all others 0.
3.4 Conclusion
BANNER, an executable survey of advances in named entity recognition, has
been shown to achieve significantly better performance than existing
open-source systems. This is accomplished using features and techniques
which are well-supported in the more recent literature. In addition to
confirming the value of these techniques and indicating that the field of
biomedical named entity recognition is making progress, this work
demonstrates that there are sufficient known techniques in the field to
achieve good results using known techniques.
This system is anticipated to be valuable to the biomedical NER
community both by providing a benchmark level of performance for
comparison and also by providing a platform upon which more advanced
techniques can be built. It is also anticipated that this work will be
immediately useful for information extraction experiments, possibly by
including minimal extensions such as a dictionary of names of types of
entities to be found.
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Chapter 4
CASE STUDY: DISEASES
Many interesting questions involving text mining require the location and
identification of diseases mentioned in biomedical text. Examples include the
extraction of associations between genes (or gene mutations) and diseases or
between drugs and diseases. Named entity recognition is the problem of
locating mentions in a text and tagging them with their semantic type, in
this case disease. Normalization is the process of determining which specific
entity the mention refers to, often by returning a unique identifier associated
with the concept. For example, the unique identifier (CUI) for myocardial
infarction in the UMLS Metathesaurus is C0027051 [87]. Note that all
mentions in any given text are needed for automatic processing, along with
their approximate locations, to determine their associations or relationships.
It has been recognized previously that biomedical entities such as
genes and proteins suffer from several problems when locating and
identifying them in biomedical text [104]. These problems include:
• The large number of names in use
• Multiple names used to refer to the same entity
• A single name used to refer to more than one entity of the same
semantic type
• Similar or identical names used to refer to entities of differing semantic
types
• Complex syntactic structures used to refer to multiple related entities
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These issues may also be relevant for the recognition and identification of
disease mentions, and that there may be other problems which are more or
less unique to this semantic type. This chapter explores the extent to which
this is true.
4.1 Related Work
There has been a significant amount of work related to locating and
identifying diseases in various kinds of biomedical text. The work closest to
the present effort is the corpus of 597 sentences from MEDLINE annotated
with disease concepts from the UMLS Metathesaurus which was created by
Jimeno et al. (2008), and is freely available online. The authors utilize this
corpus to evaluate a dictionary approach, a statistical approach and an
application of MetaMap [4] to identify diseases within the corpus. The
authors found that dictionary lookup results in an f-measure of 0.593, their
statistical method an f-measure of 0.280 and utilizing MetaMap results in an
f-measure of 0.307. However, the corpus lacks annotation of the disease
mention locations, which are needed for NER.
The corpus by Jimeno et al. was also used by Névéol et al. to improve
the application of MetaMap and also evaluate an additional technique called
the priority model [88, 109]. The authors break the corpus into a training set
with 276 sentences and a test set with 275 sentences. The authors report the
performance of the priority model at 0.80 precision, 0.74 recall and 0.77
f-measure. For the improved MetaMap method, the authors report 0.75
precision, 0.78 recall, and and 0.76 f-measure. The authors conclude that
both techniques are effective, however this study is somewhat limited by the
small size of the test set used. In addition, every test sentence included at
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least one disease mention, which may have the unfortunate effect of reporting
higher precision than would be found if the same techniques were applied to
arbitrary biomedical text.
The BioText corpus contains 3,655 sentences taken from MEDLINE
titles and abstracts [94]. It is annotated for location of disease and treatment
mentions but not concepts, and it is freely available online. The primary goal
of this corpus, however, was to explore the different types of relationships
between the diseases and treatments found, so that a high degree of
annotation consistency was not not required at the token level. This is likely
to cause the performance of systems using it to be overly pessimistic. An
assessment of BANNER, a named entity recognition system discussed further
in section 4.2, reported a performance of only 0.584 f-measure when trained
on this corpus [69].
The PennBioIE corpus contains 2,514 PubMed abstracts annotated
for tokens, parts of speech and mention location [66], and is also available
online. The corpus focuses specifically on two biomedical sub-domains,
oncology and cytochrome P450 enzymes, and does not contain the disease
concept annotations needed for normalization.
Chun et al. utilize the UMLS Metathesaurus to create a disease
dictionary, and combine several sources to create a gene dictionary [18].
They then use these to tag a corpus of 1,362,285 MEDLINE abstracts, from
which they randomly select 1,000 sentences containing both a gene mention
and a disease mention for annotation by a biologist. These sentences are
used to create a maximum-entropy model to filter out false positives reported
by the dictionary. This technique was shown to be successful for improving
the precision of the gene/disease relations found relative to the baseline of
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simple co-occurrence. The highest precision reported for disease NER is
90.0%, however recall is only reported relative to the recall of the initial
dictionary technique, indicating a 3.4% drop.
In addition to corpora, there are several systems which are capable of
identifying diseases in free text. MetaMap has already been mentioned.
Another example is Whatizit [93], which is a web service that allows a variety
of text processing modules to analyze text for the information they contain.
Whatizit currently offers three modules that can be used for locating disease
mentions in text. Two are dictionary approaches, one of which utilizes the
UMLS Metathesaurus, and the other a lexicon from healthcentral.com. The
third module offers a front end to the MetaMap system.
The primary contribution of this chapter is the creation, description
and release of a corpus of sentences from biomedical research articles which
contains annotations for both disease mention location and identification of
disease concepts. This corpus can be freely downloaded online. Moreover,
the experiment has demonstrated that the corpus is large enough to allow
training and evaluation of machine learning-based named entity recognition
systems. The similarities and differences in the automatic processing of
disease mentions as compared to other biomedical entities, particularly genes
and proteins, is also noted. As far as the authors are aware, no existing
corpus offers a substantially similar combination of properties.
4.2 Corpus
This section presents the methodology for creating the disease corpus.
Corpus statistics and analysis are also discussed. The 597 sentences sampled
by Jimeno et al. sampled from the corpus by Craven and Kumlien [25] were
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selected to start. Mention location annotations were then added and
corrected some concept identifiers to be most specific rather than most
general. When concept annotation differs that of Jimeno et al., it is noted in
the corpus. Additional sentences were then selected from the Craven corpus,
for at total of 2,784 sentences. The Craven corpus contains sentences selected
from MEDLINE abstracts via a query for six proteins. These were originally
annotated for disease concepts from OMIM as part of an analysis of
gene-disease relationships [25].
Each sentence was annotated for the location of all disease mentions,
including duplicates within the same sentence. The location of the mention
was taken to be the minimum span of text necessary to include all the tokens
required for the most specific form of the disease. The disease mention for
the phrase insulin-dependent diabetes mellitus was therefore taken to be
the entire phrase, rather than simply diabetes mellitus or diabetes. It was
determined, however, that any mention of the organism or species should not
be included. Thus, the mention for human X-linked recessive disorder
would not include human. Local abbreviations such as Huntington disease
(HD) were annotated as two separate mentions. Each mention was also
mapped - where possible - to a unique concept (CUI) in the UMLS
Metathesaurus from one of the following types:
• Disease or syndrome
• Neoplastic process
• Congenital abnormality
• Acquired abnormality
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• Experimental model of disease
• Injury or poisoning
• Mental or behavioral dysfunction
• Pathological function
• Sign or symptom
The type sign or symptom refers to entities which are not actually
diseases. However new diseases are often referred to as a set of signs and
symptoms until the disease receives an official name.
If multiple disease concepts were judged appropriate, the most specific
concept justifiable from the text or its context was used. For example, a
mention of type 2 diabetes would be annotated as type II diabetes
mellitus (C0011860) rather than the less-specific diabetes mellitus
(C0011849). It was not always possible to identify the most-specific concept
corresponding to the mention from the mention itself, necessitating the
incorporation of the surrounding context in the determination.
The corpus includes a notes field that indicates whether the mapping
is textual or intuitive. A textual mapping means that the text of the
mention was sufficient to find the concept in the UMLS Methathesaurus. An
intuitive mapping means that either context from the abstract or a subset of
the mention terms was used to locate the associated concept. Detailed
comments specify what was needed or what logic was followed to determine
the annotation applied for all intuitive annotations.
Disease names embedded in entities of other types were not annotated
as referring to the disease. Thus references to the HD gene were not taken
31
to be mentions of HD, which is the typical abbreviation for Huntington
disease. Coordinations such as Duchenne and Becker muscular dystrophy
were annotated with separate, but overlapping, disease mentions, in this case
Duchenne and Becker muscular dystrophy and Becker muscular
dystrophy. These are then mapped to the corresponding disease concepts.
Generic words such as disease or syndrome were not annotated as
disease mentions on their own, though they were included as part of a
mention that was otherwise valid.
4.3 Methods
This section describes the techniques used for named entity recognition of
diseases. The evaluation methodology and the results are also described.
4.3.1 Dictionary Techniques
The first method tested is a lexical approach through the use of dictionary
lookup. This method simply performs an exact match between the concepts
in the dictionary to the terms present in the free text. The dictionary was
comprised of the names listed in the UMLS Metathesaurus from the types
which were used to annotate the corpus.
An advantage of this method is that it automatically performs
normalization to some extent in that terms are only found if they exactly fit
the concepts defined in the dictionary. Additionally, it is also
computationally very fast. Disadvantages are that lexical variations of terms
in the dictionary cannot be dealt with and any terms not present in the
dictionary cannot be found, causing methods of this sort to suffer from low
recall. Dictionary approaches also suffer from not being able to handle
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ambiguous terms, causing a reduction in precision. Normalization techniques,
such as stemming tokens, will increase recall, and filtering techniques, such
as those utilized by Chun et al. increase precision [18]. All such techniques
do increase system complexity, however. Dictionary approaches have the
advantage of being straightforward to implement and are frequently used in
practice. They therefore also form a useful baseline with which to compare
NER systems implementing more sophisticated methods.
4.3.2 Conditional Random Field Systems
Conditional random fields is a machine learning technique which has been
applied to named entity recognition by many successful systems [104]. As a
supervised machine learning technique, it requires both training data and a
set of features. It is typically used to model NER as a sequence label
problem, where the input is a sequence of feature vectors and the output is a
sequence of labels from a predefined set. The labels are used indicate
whether the token is a part of a mention, and its type if so. CRFs model the
dependencies between the previous labels and the current label, and the
number of previous labels considered is called the order.
BANNER is a named entity recognition system based on conditional
random fields [69]. BANNER was upgraded for this study to use a dictionary
as an input feature. Improvements were also made to facilitate loading data
from differing formats for training and testing, and the updates are available
online*. The BANNER system uses a 3-stage pipeline as its method in
identifying named entities. The first stage is tokenization where BANNER
implements a simple method creating tokens by splitting contiguous
characters/digits at white space and punctuation marks. Next, feature
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generation including lemmatization (where words are transformed to their
base forms), part of speech tagging, N-grams, and others. The final step is
the use of the labeling engine utilizing conditional random fields as
implemented in the MALLET toolkit [78]. BANNER allows the training of a
1st or 2nd order model, both of which are evaluated. BANNER can also
make use of a dictionary as input. The dictionary used is comprised of the
names for all of the concepts contained in the UMLS Metathesaurus under
the types which were used for annotating the corpus, and is therefore
identical to the one employed for the dictionary approach.
The Julie Lab Named Entity Tagger, or JNET, is another named
entity recognition system based on conditional random fields [47]. JNET is
intended to be generic enough to be trained to recognize any entity type
relevant in biomedical text. It has a configurable feature set and while it can
make use of part of speech information, this must be provided externally.
JNET also does not provide the ability to use a dictionary. For this work,
JNET was modified to use the same tokenization as BANNER, which has
the effect of removing performance differences due to tokenization.
BANNER has been further extended with features based on a full
parse of each sentence using the Link Grammar parser [85]. Link Grammar is
a hybrid lexical and rule-based system for syntactic parsing that does not use
statistical techniques [103]. Previous work had shown a small but consistent
improvement in biomedical NER performance when syntactic parse features
are added [105, 118], but had not evaluated the Link Grammar parser
specifically. The work added several new feature templates, based on the
part of speech for each. One pair of feature templates indicated the set of
adjectives modifying a noun, and the noun being modified by each adjective.
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Item Count
Abstracts 794
Sentences 2,784
Tokens 79,951
Disease mentions (total) 3,228
Disease mentions (unique) 1,202
Disease concepts 686
Table 4.1: Size of the Arizona Disease Corpus, by several forms of measure-
ment.
Another feature template indicates the verb for an object. These features
were motivated by the desire to introduce longer-range dependencies into the
feature set, and resulted in a small but consistent improvement in both
precision (0.95%) and recall (0.58%), for improvement in f-measure (0.75%).
4.4 Results
This section describes the corpus and the results of the text mining study.
4.4.1 Corpus statistics
The size of the corpus is described in Table 4.1, where it is measured with
respect to the number of abstracts represented and the number of sentences,
mentions and tokens contained. Unique mentions refers to the number of
unique mention texts. Disease concepts refers to the total number of unique
disease concepts referenced in the corpus. Note there are approximately 1.75
unique mention texts per disease concept.
Several measurements were performed to gather descriptive statistics
regarding the tokens, sentences and mentions in the corpus. Figure 4.1 shows
the distribution of the number of tokens per mention. Figure 4.2 shows the
distribution of mentions per sentence. Approximately 38% of the sentences
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Figure 4.1: Number of tokens per mention in the Arizona Disease Corpus.
Figure 4.2: Number of sentences in the Arizona Disease Corpus containing a
specific number of mentions.
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Figure 4.3: Distribution of sentence lengths in the Arizona Disease Corpus.
contain no disease mentions, which is useful since most sentences in arbitrary
biomedical research text also do not contain disease mentions. Figure 4.3
describes the distribution of sentence lengths present in the corpus, which
has median 25 and positive skew. Figure 4.4 shows the relationship between
the number of tokens and the frequency with which they appear. This figure
uses a log-log plot to highlight the adherence to Zipf's law [77, 128].
4.4.2 NER Results
BANNER and JNET were evaluated using 10-fold cross validation, splitting
the corpus into 10 roughly equal parts, then training on 9 parts and then
testing on the remaining 1, and repeating 10 times so that each part is used
for testing once. The performance reported is then the average performance
of all ten runs. Since sentences from the same abstract are much more likely
to be similar than arbitrary sentences, the corpus is split so that all sentences
from the same abstract were assigned to the same split. This ensures that
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Figure 4.4: Distribution of tokens appearing in the Arizona Disease Corpus
with the specified frequency.
there will never be a sentence in the training data and one in the test data
which are from the same abstract. The dictionary method does not require
training, and performance was therefore measured against one run of the
entire corpus.
The exact matching criterion was used since it is the most strict
matching criterion and therefore provides the most conservative estimate of
performance. The precision, recall and f-measure were determined using the
standard calculations. Table 4.2 summarizes the results of the named entity
recognition study.
Dictionary lookup performed reasonably well, achieving a F-measure
of 0.622. This is slightly better than the 0.592 F-measure found by Jimeno et
al. (2008), which is probably attributable to the change in the evaluation
corpus, as the current effort is over 4.5 times larger than the corpus
employed by Jimeno et al.
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System (Variant) Precision Recall F-measure
Dictionary 0.627 0.617 0.622
BANNER (no dictionary) 0.785 0.699 0.740
BANNER (order 1) 0.795 0.744 0.768
JNET 0.824 0.727 0.772
BANNER (order 2) 0.809 0.751 0.779
Table 4.2: NER evaluation results for the dictionary method, three variants
of BANNER, and JNET, using the exact match criterion and 10-fold cross
validation.
Both of the machine learning systems significantly outperformed the
dictionary method. The best performer was found to be BANNER with an
F-measure of 0.779, with JNET following very closely at an F-measure of
0.772.
4.5 Discussion
An analysis of the number of disease concepts associated with each unique
disease mention text shows that 91% of the texts are associated with exactly
1 disease concept, and 98% of them are associated with 2 or fewer disease
concepts. This illustrates that ambiguity between disease concepts is low.
Polysemy is an issue, however, since many disease names, and
especially their variations, map to the same disease concept. As a somewhat
extreme example, familial adenomatous polyposis coli (C0032580), a
condition where numerous polyps form in the colon that are initially benign
but later turn malignant, is referred to by 13 different names in this corpus:
• 5 abbreviations: AAPC, APC, FAP, FAPC, and FPC
• 8 variations of the name attenuated familial adenomatous polyposis
coli which include polyposis but leave out one or more other terms.
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Figure 4.5: Ablation study using BANNER; the other 50% of the data was
used for testing.
The effect of using differing amounts of training data was explored by
using BANNER to perform an ablation study. The corpus was split into two
equal parts, one for training and one for testing. 11 models were then trained
using 5%, 10%, 20%, . . . 100% of the training data and then testing each on
the entire test data. The model order was reduced to order 1, since it
significantly reduces the training time required. These results are
summarized in Figure 4.5. The ablation study demonstrated that while
precision is hardly affected by the reduction in data, recall is significantly
affected, and in fact drops precipitously at about 15% of the dataset and
lower. The ablation study is also useful for extrapolating what performance
could be achieved if the corpus were made larger. Analyzing the slope of
both the precision and recall curves demonstrates that both flatten to nearly
no slope as the percentage of the corpus used for training goes up. This
suggests that, for BANNER at least, additional training data is not likely to
markedly improve the performance achieved.
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4.6 Error analysis
Output from the BANNER system was examined to investigate the errors
that occurred and provide insight into the difficulties machine learning
systems will experience in this domain. A subset of the corpus, consisting of
250 random sentences were reviewed in order to categorize the most common
sources of error.
The difficulty which the system had in identifying acronyms is one
notable source of error. The subset contained many instances of both false
positives and false negatives due to this problem. Abbreviations in
biomedical text are known to be a significant source of ambiguity [74].
Acronym disambiguation would improve accuracy to some degree, however
this would need to be applied to each mention since the primary example of
ambiguous acronyms in this corpus is the same text being used to refer to a
disease and also to the associated gene from within the same abstract.
BANNER was also observed to not handle coordinations well, such as
Becker and Duchenne muscular dystrophy. Such phrases contain two or
more mentions and are represented as such in the corpus. BANNER
frequently only tags the part of the coordination containing the contiguous
mention, which in the example would be Duchenne muscular dystrophy.
The AZDC contains 123 coordinations, with a total of 259 named entities.
The technique of Buyko et al. for resolving coordinations was implemented
and employed as a post-processing step prior to normalization candidate
generation [15]. It was determined that while BANNER only tagged the
complete coordination in 58 of the 123 sentences containing coordination
ellipsis, the method still increased the number of correct concepts found by
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the candidate generation step (which employed the Dice coefficient as a
simple string similarity measurement based on sets of tokens) by
approximately fourfold. While this method benefits normalization, the NER
step should benefit from a set of features indicating the presence and
boundaries of a coordination to improve the chance of capturing it in its
entirety.
While named entities are typically a fixed phrase, it is often natural
to refer to diseases by their effects rather than by name. Examples of this
were apparent in the difficulties the system had in tagging mentions related
to anatomical abnormalities and enzyme deficiencies. Anatomical
abnormalities are often phrased descriptively, for example, defect of the
anterior midline scalp, abnormality in ocular drainage structures or
aberrantly developed trabecular meshwork. Mentions referring to enzyme
deficiencies are similarly descriptive, for example, lack of homogentisic acid
oxidase. To correctly recognize these mentions, BANNER would benefit
from a feature noting the location and boundaries of noun phrase chunks.
These cases are relatively uncommon even so, and their recognition might
also benefit therefore from enriching the dataset using, for example, the
active-learning-like technique dynamic sentence selection [114].
BANNER is equipped with a post-processing module to detect and
handle local abbreviations such as adrenomyeloneuropathy (AMN) [99].
However, this module expects the local abbreviation to be denoted by some
form of parenthesis or bracket, which is a convention usually followed in
biomedical text, though this corpus contains several exceptions. For example,
in the sentence A 40-year-old man with childhood-onset Tourette syndrome
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(TS) developed Huntington disease HD., BANNER should correctly handle
TS, but will likely not correctly handle HD.
4.7 Conclusion
This chapter presents a new corpus of biomedical sentences, annotated both
the location of disease mentions and the identity of the disease concepts.
This corpus has been shown to enable the training of two machine-learning
based named entity recognition systems, both of which, in turn, achieve
higher performance than dictionary matching. Most of the difficulties with
other biomedical entities have also been demonstrated to be relevant for
diseases. Namely:
• There are a large number of names in use.
• Multiple names are used to refer to the same entity.
• Similar or identical names are used to refer to entities of differing
semantic types.
• Complex syntactic structures, in this case coordinations, are used to
refer to multiple related entities.
Intra-concept ambiguity, that is, the same name being used to refer to
multiple disease concepts, is not a significant concern for disease recognition
and identification, however.
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Chapter 5
CASE STUDY: ADVERSE DRUG REACTIONS
It is estimated that approximately 2 million patients in the United States are
affected each year by severe adverse drug reactions, resulting in roughly
100,000 fatalities. This makes adverse drug reactions the fourth leading
cause of death in the U.S, following cancer and heart diseases [42]. It is
estimated that $136 billion is spent annually on treating adverse drug
reactions in the U.S., and other nations face similar difficulties [73, 117].
Unfortunately, the frequency of adverse drug reactions is often
under-estimated due to a reliance on voluntary reporting [5, 117].
While severe adverse reactions have received significant attention, less
attention has been directed to the indirect costs of more common adverse
reactions such as nausea and dizziness, which may still be severe enough to
motivate the patient to stop taking the drug. The literature shows, however,
that non-compliance is a major cause of the apparent failure of drug
treatments, and the resulting economic costs are estimated to be quite
significant [58, 116]. Thus, detecting and characterizing adverse drug
reactions of all levels of severity is critically important, particularly in an era
where the demand for personalized health care is high.
An adverse drug reaction is generally defined as an unintended,
harmful reaction suspected to be caused by a drug taken under normal
conditions [71, 122]. This definition is sufficiently broad to include such
conditions as allergic reactions, drug tolerance, addiction or aggravation of
the original condition. A reaction is considered severe if it results in death,
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requires hospital admission or prolongation. . . , results in persistent or
significant disability/incapacity, or is life-threatening, or if it causes a
congenital abnormality [71].
The main sources of adverse drug reaction information are clinical
trials and post-marketing surveillance instruments made available by the
Food and Drug Administration (FDA), Centers for Disease Control and
Prevention (CDC) in the United States, and similar governmental agencies
worldwide. The purpose of a clinical trial, however, is only to determine
whether a product is effective and to detect common serious adverse events.
Clinical trials, by their nature and purpose, are focused on a limited number
of participants selected by inclusion/exclusion criteria reflecting specific
subject characteristics (demographic, medical condition and diagnosis, age).
Thus, major uncertainties about the safety of the drug remain when the drug
is made available to a wider population over longer periods of time, in
patients with co-morbidities and in conjunction with other medications or
when taken for off-label uses not previously evaluated.
Recently, the regulatory bodies of both the U.S. and the U.K. have
begun programs for patient reporting of adverse drug reactions. Studies have
shown that patient reporting is of similar quality to that of health
professionals, and there is some evidence that patients are more likely to
self-report adverse drug reactions when they believe the health professionals
caring for them have not paid sufficient attention to an adverse reaction [9].
In general, however, the FDA advocates reporting only serious events
through MedWatch.
Self-reported patient information captures a valuable perspective that
might not be captured in a doctor's office, clinical trial, or even in the most
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sophisticated surveillance software. For this reason, the International Society
of Drug Bulletins asserted in 2005 that patient reporting systems should
periodically sample the scattered drug experiences patients reported on the
internet.
Social networks focusing on health related topics have seen rapid
growth in recent years. Users in an online community often share a wide
variety of personal medical experiences. These interactions can take many
forms, including blogs, microblogs and question/answer discussion forums.
For many reasons, patients often share health experiences with each other
rather than in a clinical research study or with their physician [28]. Such
social networks bridge the geographical gap between people, allowing them
to connect with patients who share similar conditionssomething that might
not be possible in the real world.
This chapter proposed and evaluated automatically extracting
relationships between drugs and adverse reactions in user posts to
health-related social network websites. This technique will provide valuable
additional confirmation of suspected associations between drugs and adverse
reactions. Moreover, it is possible this technique may eventually provide the
ability to detect novel associations earlier than with current methods.
5.1 Related Work
In the work closest in purpose to this study, two reviewers manually analyzed
1,374 emails to the BBC and 862 messages on a discussion forum regarding a
link between the drug paroxetine and several adverse reactions including
withdrawal symptoms and suicide [80]. The authors concluded that the user
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reports contained clear evidence of linkages that the voluntary reporting
system then in place had not detected.
Not much work has been done to automatically extract adverse
reactions from text, other than the SIDER side effect resource, which was
created by mining drug insert literature [65]. There is, however, significant
literature support for mining more general concepts, such as diseases.
MetaMap is a primarily lexical system for mapping concepts in biomedical
text to concepts in the UMLS Metathesaurus [4]. The ConText system
categorizes findings in clinical records as being negated, hypothetical, or
historical [51].
Most of the work on finding diseases concerns either biomedical text or
clinical records. A notable exception is the BioCaster system, which detects
infectious disease outbreaks by mining news reports posted to the web [22].
Health social networks have become a popular way for patients to
share their health related experiences. A considerable amount of research has
been devoted to this area [84], but most of this work has focused on the
study of social interactions and quality evaluation instead of text mining.
Automated information extraction from health social network websites
remains largely unexplored.
5.2 Data Preparation
The DailyStrength1 health-related social network was used as the source of
user comments in this study. DailyStrength allows users to create profiles,
maintain friends and join various disease-related support groups. It serves as
a resource for patients to connect with others who have similar conditions,
1http://www.dailystrength.org
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many of whom are friends solely online. As of 2007, DailyStrength had an
average of 14,000 daily visitors, each spending 82 minutes on the site and
viewing approximately 145 pages [24].
5.2.1 Data Acquisition
To efficiently gather user comments about specific drugs from the
DailyStrength site, a highly parallelized automatic web crawler was
implemented. All data was scraped from the raw HTML using regular
expressions since the site has no open API. Users indicate a specific
treatment when posting comments to DailyStrength, however treatments
which are not drugs were filtered. For each user comment the user ID,
disease name, drug name, and comment text were extracted. While more
information about each user is available at the site (gender, age, self-declared
location, and length of membership at the site), only the comment data were
used. The DailyStrength Privacy Policy states that comments made by users
will be publicly available. All data was gathered in accordance with the
DailyStrength Terms of Service, and to respect fair use the data will not be
made publicly available without permission from the site.
5.2.2 Preparing the Lexicon
To enable finding adverse reactions in the user comments, a lexicon was
created by combining terms and concepts from four resources.
The UMLS Metathesaurus is a resource containing many individual
biomedical vocabularies [87]. The subset used was limited to the COSTART
vocabulary created by the U.S. Food and Drug Administration for
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post-marketing surveillance of adverse drug reactions, which contains 3,787
concepts.
The SIDER side effect resource contains 888 drugs linked with 1,450
adverse reaction terms extracted from pharmaceutical insert literature [65].
The raw term found in the literature and the associated UMLS concept
identifier (CUI) were used.
The Canada Drug Adverse Reaction Database, or MedEffect2,
contains associations between 10,192 drugs and 3,279 adverse reactions,
which was used to create a list of adverse reaction terms. Many adverse
reaction terms were found with very similar meanings, for example appetite
exaggerated, and appetite increased, which were grouped together
manually.
A small set of colloquial phrases were also included. These were
collected manually from a subset of the DailyStrength comments and
mapped to UMLS CUIs. This list is available3, and includes the terms
throw up, meaning vomit, gain pounds, meaning weight gain, and
zonked out, meaning somnolence.
All terms which are associated with the same UMLS concept identifier
(CUI) as were considered to be synonymous and were grouped into a single
concept. All concepts containing a term in common were also merged into a
single unified concept. The lexicon contains 4,201 unified concepts, each
containing between one and about 200 terms.
2http://www.hc-sc.gc.ca/dhp-mps/medeff/index-eng.php
3http://diego.asu.edu/downloads/adrs
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Drug name (Brand name) Primary Indications
carbamazepine (Tegretol) epilepsy, trigeminal neuralgia
olanzapine (Zyprexa) schizophrenia, bipolar disorder
trazodone (Oleptro) depression
ziprasidone (Geodon) schizophrenia
aspirin pain, fever, reduce blood clotting
ciprofloxacin (Cipro) bacterial infection
Table 5.1: List of drugs included in the subset for analysis and their primary
indications.
5.3 Annotation
Comments relating to the following 4 drugs were annotated: carbamazepine,
olanzapine, trazodone, and ziprasidone. These drugs were chosen because
they are known to cause adverse reactions. The blood pressure medication
clonidine was considered for inclusion, however it was eliminated from
further consideration since a preliminary analysis demonstrated that many
users confused it with the infertility drug clomifene. Comments for the drugs
aspirin and ciprofloxacin were retained but not annotated; these comments
are used during evaluation. These drugs are listed along with their primary
indications in table 5.1. The data contains a total of 6,890 comment records.
User comments were selected for annotation randomly and were
independently annotated by two annotators.
Annotator 1 has a BS in biology, 10 years nursing experience in the
behavioral unit of a long term care facility, and has dispensed all of the drugs
annotated. Annotator 2 has a BS and an MS in neuroscience, and has work
experience in data management for pharmaceutical-related clinical research
and post-marketing drug surveillance.
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Concept Definition
Adverse effect A reaction to the drug experienced by the pa-
tient, which the user considered negative
Beneficial effect A reaction to the drug experienced by the pa-
tient, which the user considered positive
Indication The condition for which the patient is taking the
drug
Other A disease or reaction related term not character-
izable as one of the above
Table 5.2: The concepts annotated in this study and their definitions.
5.3.1 Concepts Annotated
Each comment was annotated for mentions of adverse effects, beneficial
effects, indications and other terms, as defined in table 5.2. Each annotation
included the span of the mention and the name of the concept found, using
entries from the lexicon described in section 5.2.2. Each annotation also
indicates whether it refers to an adverse effect, a beneficial effect, an
indication or an other term, which shall be hereafter termed its
characterization.
5.3.2 Annotation Practices
There are four aspects which require careful consideration when
characterizing mentions. First, the stated concept may or may not be
actually experienced by the patient; mentions of concepts not experienced by
the patient were categorized as other. Second, the user may state that the
concept is the reason for taking the drug. If so, the mention was categorized
as an indication. Third, the concept may be an effect caused by the drug. In
this case, the mention is categorized as either an adverse effect or a beneficial
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effect based on whether the user considers the effect a positive one. This
requires some judgment regarding what people normally view as positive 
while sleepiness is normally an adverse effect, someone suffering from
insomnia would consider it a beneficial effect, regardless of whether insomnia
is the primary reason for taking the drug. Mentions of concepts which were
experienced by the patient but neither an effect of the drug nor the reason
for taking it were also categorized as other. Concepts were characterized as
an adverse effect unless the context indicated otherwise.
Comments not containing a mention or that only indicated the
presence of an adverse effect (Gave me weird side effects) were discarded. If
more than one mention occurred in a comment, then each mention was
annotated separately.
Some comments clearly mentioned an adverse reaction, but the
reaction itself was ambiguous. For example, in the comment It did the job
when I was really low. However, I BALLOONED on it, the annotator could
infer BALLOONED to mean either weight gain or edema. A frequent
example is colloquial terms such as zombie, which could be interpreted as a
physiological effect (e.g. fatigue) or a cognitive effect (e.g. mental dullness).
In such cases, each mention was annotated by using both the context of the
mention and annotator's knowledge of the effects of the drug.
Spans were annotated by choosing the minimum span of characters
from the comment that would maintain the meaning of the term. Locating
the mention boundaries was straightforward in many cases, even when
descriptive words were in the middle of the term (It works better than the
other meds ive taken but I am gaining some weight). However some
comments were not as simple (it works but the pounds are packing on).
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Sample Comments Annotations
hallucinations and weight gain hallucinations - hallucinations: adverse
effect; weight gain - weight gain: adverse
effect
This has helped take the edge off
of my constant sorrow. It has also
perked up my appetite. I had lost
a lot of weight and my doctor was
concerned.
constant sorrow - depression: indication;
perked up my appetite - appetite in-
creased: beneficial effect; lost a lot of
weight - weight loss: other
It worked well, but doctor didn't
asked for the treatment to continue
once my husband was doing well
again.
none
ARGH! Got me nicely hypomanic
for two weeks, then pooped out on
me and just made me gain a half
pound a day so I had to stop.
hypomanic - hypomania: beneficial ef-
fect; pooped out - tolerance: adverse ef-
fect; gain a half a pound a day - weight
gain: adverse effect
Works to calm mania or depression
but zonks me and scares me about
the diabetes issues reported.
mania - mania: indication; depression -
depression: indication; zonks me - som-
nolence: adverse effect; diabetes - dia-
betes: other
Works for my trigeminal neuralgia.
Increasing to see if it helps stabalize
mood. Fatigue!
trigeminal neuralgia - trigeminal neural-
gia: indication; stabalize mood - emo-
tional instability: indication; Fatigue -
fatigue: adverse effect
Take for seizures and bipolar works
well
seizures - seizures: indication; bipolar
- bipolar disorder: indication
fatty patti! fatty - weight gain: adverse effect
Table 5.3: An illustrative selection of uncorrected comments submitted to the
DailyStrength health-related social networking website, and their associated
annotations.
5.3.3 Corpus Description
A total of 3,600 comments were annotated, a sample of which can be seen in
table 5.3. 450 comments were reserved for system development. The
annotators found 1,260 adverse effects, 391 indications, 157 beneficial effects
and 78 other, for a total of 1,886 annotations.
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The agreement between annotators was measured by calculating both
kappa (κ) [19] and inter-annotator agreement (IAA). For κ, agreement was
considered to mean that the concept terms were in the same unified concept
from the lexicon and the characterization of the mentions matched, since
there is no standard method for calculating κ which includes the span. For
IAA, an additional constraint was added that the annotation spans must
overlap, since discussions of IAA typically include the span. Using these
definitions, κ was calculated to be 85.6% and IAA to be 85.3%4.
5.4 Text Mining
Since the drug name is specified by the user when the comment is submitted
to DailyStrength, no extraction was necessary for drug names. To extract
the adverse drug reactions from the user comments, a primarily lexical
method was implemented, utilizing the lexicon discussed in section 5.2.2.
5.4.1 Methods Used
Each user comment was split into sentences using the Java sentence breaker,
tokenized by splitting at whitespace and punctuation, and tagged for
part-of-speech using the Hepple tagger [53]. Stop-words were removed from
both user comments and lexical terms5. Tokens were stemmed using the
Snowball implementation of the Porter2 stemmer6.
Terms from the lexicon were found in the user comments by
comparing a sliding window of tokens from the comment to each token in the
lexical term. The size of the window is configurable and set to 5 for this
study since that is the number of tokens in the longest term found by the
4κ>IAA here due to the different definitions of agreement.
5http://ir.dcs.gla.ac.uk/resources/linguistic_utils/stop_words
6http://snowball.tartarus.org
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annotators. Using a sliding window allows the tokens to be in different orders
and for there to be irrelevant tokens between the relevant ones, as in weight
gain and gained a lot of weight.
Since user comments contain many spelling errors, the Jaro-Winkler
measurement of string similarity was used to compare the individual tokens
[121]. The similarity between the window of tokens in the user comment and
the tokens in the lexical term was scored by pairing them as an assignment
problem [14]. The similarities of the individual tokens was then summed and
normalized the result by the number of tokens in the lexical term. This score
is calculated for both the original tokens and the stemmed tokens in the
window, and the final score is taken to be the higher of the two scores. The
lexical term is considered to be present in a user comment if the final score is
greater than a configurable threshold.
It was found that most mentions could be categorized by using the
closest verb to the left of the mention, as in taking for seizures. As this
study focuses on adverse effects, a filtering method was implemented to
remove indications, beneficial effects, and other mentions on a short list of
verbs which indicate them. Verbs on this list include helps, works, and
prescribe all of which generally denote indications. The complete list is
available7.
5.4.2 Text Mining Results
The system was first evaluated against the 3,150 annotated comments not
reserved for system development. The evaluation was limited to adverse
effects because the purpose is to find adverse drug reactions. This evaluation
7http://diego.asu.edu/downloads/adrs
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used a strict definition of true positive, requiring the system to label the
mention with a term from the same unified concept as the annotators. The
results of this study are 78.3% precision and 69.9% recall, for an f-measure of
73.9%.
Since the purpose of this study is to determine if mining user
comments is a valid way to find adverse reactions, the system was run on all
available comments and compared the frequencies of adverse reactions found
against their documented incidence. The frequency that each adverse effect
was found in the user comments for each of the drugs studied in this
experiment was counted. The most commonly found adverse reactions for
each drug were then determined and compared against the most common
documented adverse reactions for the drug. Since the four drugs chosen for
annotation all act primarily on the central nervous system, aspirin and
ciprofloxacin were added for this study. The results of this evaluation contain
encouraging correlations that are summarized in table 5.4.
5.5 Discussion
The experiment comparing the documented incidence of adverse reactions to
the frequency they are found contained some interesting correlations and
differences. The adverse reaction found most frequently for all 6 of the drugs
corresponded to a documented adverse reaction. There were also similarities
in the less common reactions, such as diabetes with olanzapine and bleeding
with aspirin. In addition, many of the adverse reactions found corresponded
to documented, but less common, reactions to the drug. Examples of this
included edema with olanzapine, nightmares with trazodone, weight gain
with ziprasidone, tinnitus with aspirin, and yeast infection with ciprofloxacin.
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Drug name
(Brand
name)
Documented Adverse
Effects (Frequency)
Adverse Effects Found in User
Comments (Frequency)
carbamazepine
(Tegretol)
dizziness, somnolence
or fatigue, unsteadi-
ness, nausea, vomiting
somnolence or fatigue (12.3%), al-
lergy (5.2%), weight gain (4.1%),
rash (3.5%), depression (3.2%), dizzi-
ness (2.4%), tremor/spasm (1.7%),
headache (1.7%), appetite increased
(1.5%), nausea (1.5%)
olanzapine
(Zyprexa)
weight gain (65%),
alteration in lipids
(40%), somnolence
or fatigue (26%),
increased cholesterol
(22%), diabetes (2%)
weight gain (30.0%), somnolence
or fatigue (15.9%), appetite in-
creased (4.9%), depression (3.1%),
tremor (2.7%), diabetes (2.6%), ma-
nia (2.3%), anxiety (1.4%), hallucina-
tion (0.7%), edema (0.6%)
trazodone
(Oleptro)
somnolence or fa-
tigue (46%), headache
(33%), dry mouth
(25%), dizziness (25%),
nausea (21%)
somnolence or fatigue (48.2%), night-
mares (4.6%), insomnia (2.7%), ad-
diction (1.7%), headache (1.6%), de-
pression (1.3%), hangover (1.2%),
anxiety attack (1.2%), panic reaction
(1.1%), dizziness (0.9%)
ziprasidone
(Geodon)
somnolence or fatigue
(14%), dyskinesia
(14%), nausea (10%),
constipation (9%),
dizziness (8%)
somnolence or fatigue (20.3%), dysk-
inesia (6.0%), mania (3.7%), anxiety
attack (3.5%), weight gain (3.2%),
depression (2.4%), allergic reaction
(1.9%), dizziness (1.2%), panic reac-
tion (1.2%)
aspirin nausea, vomiting, ul-
cers, bleeding, stomach
pain or upset
ulcers (4.5%), sensitivity (3.8%),
stroke (3.1%), bleeding time in-
creased (2.8%), somnolence or fa-
tigue (2.7%), malaise (2.1%), weak-
ness (1.4%), numbness (1.4%), bleed-
ing (1.0%), tinnitus (0.7%)
ciprofloxacin
(Cipro)
diarrhea (2.3%), vomit-
ing (2.0%), abdominal
pain (1.7%), headache
(1.2%), restlessness
(1.1%)
abdominal pain (8.8%), malaise
(4.4%), nausea (3.8%), allergy
(3.1%), somnolence or fatigue
(2.5%), dizziness (1.9%), weakness
(1.6%), tolerance (1.5%), rash
(1.3%), yeast infection (1.1%)
Table 5.4: List of drugs analyzed, with the 5 most common adverse effects,
their frequency of incidence in adults taking the drug over the course of one
year (if available) and the 10 most frequent adverse effects found in the the
DailyStrength data using the automated system.
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One interesting difference is the relative frequency of hangover in
the comments for ziprasidone. Since the users were not likely referring to a
literal hangover, they were probably referring to the fatigue, headache, dry
mouth and nausea that accompany a hangover, all of which are documented
adverse reactions to the drug.
Users frequently commented on weight gain and fatigue while ignoring
other reactions such as increased cholesterol. While this may be because
users are more conscious of issues they can directly observe, this hypothesis
would not explain why other directly observable reactions such as nausea and
constipation are not always reported. Determining the general trends in the
differences between clinical and user reports is an important area for future
work.
5.5.1 Error Analysis
An analysis was performed to determine the primary sources of error for the
extraction system. 100 comments were randomly selected and determined the
reason for the 24 false positives (FPs) and 29 false negatives (FNs) found.
The largest source of error (17% of FPs and 55% of FNs) was the use
of novel adverse reaction phrases (liver problem) and descriptions (burn
like a lobster). This problem is due in part to idiomatic expressions, which
may be handled by creating and using a specialist lexicon. This problem
might also be partially relieved by the appropriate use of semantic analysis.
However, this source of error is also caused by the users deliberately
employing a high degree of linguistic creativity (TURNED ME INTO THE
SPAWN OF SATAN!!!) which may require deep background knowledge to
correctly recognize.
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The next largest source of error was poor approximate string matching
(46% of FPs and 17% of FNs). While users frequently misspelled words,
making lexical analysis difficult, the approximate string matching technique
used also introduced many FPs. Spelling unfamiliar medical terminology is
particularly difficult for users. Correcting this important source of error will
require improved modeling of the spelling errors made by users.
Ambiguous terms accounted for 8% of the FPs and 7% of the FNs.
While this is frequently a problem with colloquial phrases (brain fog could
refer to mental dullness or somnolence), there are some terms which are
ambiguous on their own (numb may refer to loss of sensation or emotional
indifference). These errors can be corrected by improving the analysis of the
context surrounding each mention.
Surprisingly, miscategorizations only accounted for 4% of the FPs.
This small percentage seems to indicate that the simple filtering technique
employed is reasonably effective. However this source of error can be seen
more prominently in the frequency analysis, as seen in table 5.4. For
example, one of the most frequent effects found in comments about
trazodone was insomnia, which is one of its most common off-label uses.
Other examples included depression with olanzapine, mania with
ziprasidone, and stroke with aspirin. The remaining errors include one
unrecognized term, hungry, and a phrase which was spread across two
sentences (worked . . . then stopped). While this error is not common, the
method may benefit from an extension to handle negation, since conditions
not being experienced by the patient are always categorized as other.
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5.5.2 Limitations
The present study has some limitations. The demographics of the users
whose comments were mined were not analyzed, though it is likely that they
are predominantly from North America and English-speaking. Future work
should include expansion of the range of users and compare their
demographics against clinical studies of adverse reactions. Also, the drugs
annotated operate primarily on the central nervous system and therefore have
different adverse reaction profiles than would other drugs with substantially
different mechanisms. While the inclusion of aspirin and ciprofloxacin does
provide some evidence these techniques are more generally applicable, the
range of drugs studied should also be expanded in future work.
5.5.3 Opportunities for Further Study
In addition to the current classification for adverse reactions, there are
additional dimensions along which each user comment could be studied. For
example, many comments describe the degree of the adverse reaction, which
can be straightforward (extremely) or more creative (like a pig). Also,
many users explicitly state whether they are still taking the drug, typically
indicating whether their physician took them off or whether they took
themselves off (non-compliance), and whether adverse reactions were the
reason. User comments can also be categorized as medically non-descriptive
(I took one tablet and could'nt get out of bed for days and felt like I got hit
by a truck), somewhat medically descriptive (My kidneys were not
functioning properly), or medically sound (I ended up with severe leg
swelling). Comments also typically indicate whether the user is the patient
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or a caretaker by being phrased in either the first person or third person
narrative. Finally, users also frequently describe whether they thought the
benefits of the drug outweighed the adverse effects. These additional
dimensions represent a fertile area for further research.
5.6 Conclusion
In summary, user comments to health related social networks have been
shown to contain extractable information relevant to pharmacovigilance.
This approach should be evaluated for the ability to detect novel
relationships between drugs and adverse reactions.
In addition to the improvements discussed in section 5.5, future work
will increase the scale of the study (additional drugs, additional data sources,
more user comments), improve the characterization of reactions using
rule-based patterns, and evaluate the improved system with respect to all
characterizations.
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Chapter 6
MULTIVARIATE FEATURE SELECTION WITH FALSE DISCOVERY
RATE CONTROL
Feature extraction creates many features of relatively low quality. This
chapter now turns to improving the feature set quality by removing these
poor features with feature selection. For a feature selection algorithm to be
successful for biomedical NER, it should be able to handle extremely
unbalanced distributions. The technique should also be able to handle high
degrees of feature redundancy and control for multiple comparisons in a wide
dataset. Moreover, the feature set created should be stable. In addition,
since training conditional random fields requires significant computational
resources, there is a strong preference for efficient techniques focus solely on
filter-based feature selection in this chapter.
6.1 Related Work
Feature selection methods can be categorized into three groups: wrappers,
filters and embedded methods [44]. Wrapper methods select features by
alternating rounds of training a model and either adding or removing
features. For example, recursive feature elimination trains a model using the
entire feature set and then analyzes the model to select a set of features to
remove because of low weight [46]. The second group, the filter methods,
selects a set of features prior to training any model. These techniques
typically rank the features according to a measure of relevance, and then
select a subset by setting a threshold. Since these methods only train one
model, they are considerably more computationally efficient than the
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wrapper methods. The third type of feature selection methods are the
embedded techniques. These methods include feature selection as part of the
training process through techniques such as regularization.
The literature on feature selection outside of biomedical NER is vast,
though most of the work is heuristic rather than theoretical. Only a few of
the works most important for the present effort are presented, and the reader
is referred to a reference for a more comprehensive discussion [45, 76].
A very recent work unifies many filter-based feature selection
algorithms under a single framework [13]. The authors take a theoretical
perspective of feature selection and use conditional likelihood maximization
to derive the metric whose optimal value corresponds to the optimal feature
set. The authors show that optimal feature selection must consider
conditional relevance, that is, the relevance of a feature not already provided
by other members of the feature set. This implies that removing redundant
features need not always improve the classification performance. Moreover,
the authors demonstrate that many successful feature selection heuristics are
actually approximations of the full optimization problem derived by the
authors. These include important algorithms such as fast correlation-based
filtering (FCBF) [126], incremental association markov blanket (IAMB) [113],
and mutual information maximization (MIM) [75]. The authors conclude
that the joint mutual information (JMI) algorithm is the best approximation
of the optimal objective function for accuracy and stability [82, 123].
6.1.1 Multiple comparisons
One of the most important concepts for feature selection is multiple
comparisons, the fact that the probability of finding a statistically significant
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association increases with the number of variables tested [60]. While multiple
comparisons can be controlled using Bonferroni correction, this technique is
conservative in the case of correlated or dependent variables and therefore
not appropriate for every problem. Another technique, called the false
discovery rate, has been introduced to allow controlling multiple comparison
by limiting the percentage of features falsely considered relevant [8].
Assuming a large number of probes and a small number of relevant features,
Guyon et. al. show that the ceiling for the false discovery rate can be
estimated as follows:
FDR ≤ nsp
np
nc
nsc
Where:
• nsp is number of selected probes
• np is total number of probes
• nc is total number of candidates
• nsc is number of selected candidates
Probes are never added to the feature set and are therefore not used
to build the final model. The false discovery rate can be used to stop feature
selection when the false discovery rate reaches a specified point. The power of
different feature selection algorithms for a given dataset can be compared by
determining the number of features selected at different false discovery rates.
6.1.2 Feature Selection for NER
There have been relatively few evaluations of feature selection for biomedical
NER. The first work evaluating feature sets for biomedical NER used
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recursive feature elimination to reduce the feature set for a system using a
support vector machine to classify tokens in a sliding window [49]. The
authors demonstrate a 0.7% increase in the overall performance using the
best feature set found using this method, and were also able to show that a
performance only 2.3% lower than the maximum is achievable with less than
5% of the features.
A more recent study selected the most useful features for a biomedical
NER problem by setting manual thresholds for the feature occurring and for
the feature occurring inside a mention [83]. Features which fell below the
thresholds were discarded and not used for training or evaluation, which
would tend to increase both stability and generalization. The authors show
an approximately 2% improvement in the f-measure using their technique.
The most recent work analyzes several feature selection methods on
an NER system based on conditional random fields [62]. The authors
evaluate the two most popular filtering methods, information gain and the χ2
test, in addition to a wrapper technique, iterative feature pruning. The
authors show that IG out-performs χ2, and indicate a belief that this is due
to the extreme class imbalance. Other research confirms that the χ2 test is
less accurate than information gain for very low counts [35]. The authors
note that even the random baseline can be used to remove 30-40% of the
original feature set without significantly impacting the achievable f-measure,
implying a high degree of feature redundancy.
6.2 Methods
In a very recent work previously discussed in the survey of feature selection,
the joint mutual information (JMI) feature selection score was shown to have
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the best overall balance between considering feature relevance and feature
interactions [13, 82, 123]. This technique is therefore applied to biomedical
NER. As this technique already handles redundant features, extensions are
proposed which allow high imbalance and false discovery rate analysis with
probes.
JMI is a sequential search algorithm, adding one feature to the feature
set at a time by selecting the feature with the highest JMI score. The JMI
score is a function of the current feature set, and may increase or decrease as
the feature set changes.
The JMI score for a feature not yet accepted can be calculated
incrementally, so that the each round only requires a number of operations
proportional to the number of features left to consider.
To determine when to stop adding new features, the feature selection
is augmented with false discovery rate analysis using the probes technique, as
described in the survey of feature selection. This is straightforward since JMI
is a sequential search algorithm.
While NER features are binary, there is a significant imbalance
between the number of true and false values for individual features. The
probes should therefore not assume that the probability of a true and a false
are approximately equal. Instead, the observed probability of a true value for
each feature is calculated according to the feature set. To create the probes,
the original feature set is assumed to be a set of binary random variables
x1 . . . xn with observed probability of success p1 . . . pn. A set of probes is
created, r1 . . . rn, each modeled by a Bernoulli distribution with probability
of success chosen with replacement from p1 . . . pn. Since the features are
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highly imbalanced, the correct number of successes for each probe are
guaranteed by instantiating a sparse vector of the same length as the number
of tokens in the training set, ensure that it contains the correct number of
successes, and then permute it.
6.3 Results
JMI with false discovery rate analysis was evaluated on the BioCreative 2
Gene Mention data and the NCBI Disease dataset. For the BioCreative 2
Gene Mention dataset, JMI selected 107 features prior to selecting any
probes, for an estimated FDR of 0%. However the estimated FDR climbs to
over 50% over the next 5 features accepted. For the NCBI Disease dataset,
57 features are selected prior to selecting any probes, again for an estimated
FDR of 0%. In this case, however, only probes are selected after this point,
so that to the estimated FDR climbs to over 50% with no more features
selected.
A BANNER model was created using only the features selected by
JMI with a FDR of 0%. Normally an FDR threshold of 0% would be too
restrictive, but since the FDR climbs so quickly after that point it was not
considered critical to set the threshold more carefully. The results can be
seen in table 6.1.
6.4 Discussion
Using JMI as a feature selection method did not result in improved
performance. For the BioCreative 2 Gene Mention corpus, precision dropped
by 0.199 and recall dropped by more than 0.439. For the NCBI Disease
corpus, precision dropped by 0.124 and recall dropped by more than 0.188.
Given the very few features selected, a significant reduction in performance is
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System (Variant) Corpus Precision Recall F-measure
BANNER, order 1 NCBI Disease 0.825 0.785 0.805
Using only features
selected by JMI
NCBI Disease 0.701 0.617 0.656
BANNER, order 1 BioCreative 2 GM 0.860 0.834 0.847
Using only features
selected by JMI
BioCreative 2 GM 0.635 0.408 0.496
Table 6.1: NER evaluation results for joint mutual information with FDR
control.
not unexpected. It is also expected that fewer features would affect recall
more than precision. Considering that that the full feature set constitutes
hundreds of thousands of features, however, the performance achieved with
three orders of magnitude fewer features is surprisingly high.
It is interesting that JMI selected only a few features before selecting
mostly probes, causing the false discovery rate to climb quickly. The
behavior of selecting probes almost exclusively after some point is somewhat
interesting since it is so different from the behavior of univariate feature
selection measures, whose probability of selecting a probe increases gradually
as more features are accepted. This behavior is explained by the amount of
new information remaining in the unselected features being less than the
amount of new information apparently present in the probes. This is
evidence, however, that the feature set created by the rich feature set
approach has different properties than feature sets studied in other domains.
It also suggests that the feature set returned by JMI may be too closely
adapted to the training set, implying that the feature set itself is, in a sense,
overtrained.
To test this hypothesis, 5 iterations of JMI over bootstrap samples
were run, consisting of 50% of the BioCreative 2 Gene Mention dataset. JMI
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was found to have repeated the behavior of selecting a number of features
without selecting any probes, then selecting mostly probes. The result was
an average of 83 features selected at 0% estimated FDR, with only 33
features present in all 5 models. This indicates a high degree of instability in
the feature set chosen, and since the only difference between the data for the
models was the training set, this is evidence that the feature set is too closely
adapted to the training set.
6.5 Conclusion
In conclusion, joint mutual information was unable to select a higher
performing feature set than simply selecting all features. However since
linear-chain conditional random fields is based on a finite state machine, the
feature set is different for each transition in the machine. The feature
selection employed only allowed features to be available or unavailable for all
transitions. It is possible that allowing features to be selected for each
transition individually would enable a performance increase. It is also
possible that the redundancy in the feature set is important, and that there
are no features which can be removed while simultaneously supporting a
performance improvement. Additional work in feature selection for named
entity recognition may enable the performance improvements sought.
6.5.1 Future Work
Other recent work with false discovery rate analysis on high-dimensional
data suggests that the technique stability selection may be useful. Stability
selection creates a feature selection filter by combining many supervised
classifiers into an ensemble [81]. Each model in the ensemble is trained using
L1 regularization, causing the weight for many features to be pushed down to
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exactly zero, which is equivalent to removing these features from the feature
set.
The authors show that the probability that a feature has a nonzero
weight in the ensemble models is both highly correlated with the feature
being relevant and is highly stable. In addition, the technique is not
sensitively dependent on the choice of the L1 regularization parameter, and
the probability threshold can be varied to control the false discovery rate.
The resulting feature set is then used to create a final classification model.
The analysis allowing FDR calculations assumes that the features are
independent and identically distributed, which is not accurate, and the
results of the experiment with JMI suggests that this assumption may be
problematic. In addition, when the feature set contains several useful
features that are highly correlated, the algorithm will usually select none of
them. The reason is that L1 regularization arbitrarily selects only one
feature from a set of duplicate features, resulting in none of them being
selected frequently enough individually. This can be solved using the elastic
net  a linear combination of L1 and L2 regularization that results in a
sparse feature set that is significantly more stable [129].
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Chapter 7
INCORPORATING LEXICONS THROUGH LANGUAGE MODELING
This chapter describes a novel method for characterizing the content of token
sequences by adapting methods from terminology extraction and language
modeling. The purpose is to enable the creation of a novel technique for
named entity recognition, intended to be used as a feature. The technique
proposed utilizes language modeling as a way to describe how common
specific sequences are in a corpus of interest, and uses the difference between
the probability of the sequence appearing in two corpora to characterize the
likelihood that this sequence appeared in one of them.
The purpose of this technique is to allow more efficient use of domain
resources such as lexicons as features for named entity recognition. While
many entities of interest lack lexicons and other domain resources, such
resources do exist for many of the most important entities, including genes,
proteins, diseases, known genomic variations, species, and many more. Given
the significant investment required to create such domain resources, it would
be useful to take advantage of them when they are available.
7.1 Related work
These methods are strongly inspired by work in terminology extraction,
which is the problem of locating terms, or multi-token sequences, which refer
to entities of interest in a particular domain. In terminology extraction the
output is a list of terms, analogous to a list of unique mentions in NER.
However in terminology extraction, the locations that each term was found
and the semantic type is not considered relevant. Terms are, however,
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frequently given a score representing how strongly the sequence appears to
be a term in the text of interest.
One classic paper in terminology extraction uses the relative
frequency ratio to locate terms of interest by comparing the relative
frequency of a term in a foreground corpus with the relative frequency of
that term in a background corpus [26]. The foreground corpus is taken to be
a large amount of text known to be relevant to the domain of interest, while
the background text is taken to be a large amount of unlabeled text from a
wider domain. The relative frequency ratio is defined as follows:
Rw(p||q) = p(w)
q(w)
Where:
• p(w) is the probability of the phrase w appearing in the forground
corpus
• q(w) is the probability of the phrase w appearing in the background
corpus
The authors were able to demonstrate that the relative frequency ratio was
effective in locating bigrams, expressions of length two, that are important
for the chosen domain.
The relative frequency ratio has been criticized as being too sensitive
to the frequency of the term in the background corpus, giving especially high
weight to terms which appear infrequently or not at all, regardless of their
frequency in the foreground corpus. More recent work extends the idea of
comparing the distributions of phrases between two corpora by using the
pointwise Kullback-Leibler (KL) divergence, which the authors define as
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describing informativeness [111]. The pointwise KL divergence is defined as
the amount contributed by a single phrase w to the KL divergence, and is
calculated as follows:
δw(p||q) = p(w)logp(w)
q(w)
Where:
• p(w) is the probability of the phrase w appearing in the forground
corpus
• q(w) is the probability of the phrase w appearing in the background
corpus
The pointwise KL divergence is a measurement of the information lost
when the phrase is considered to have come from the background corpus,
modeled by q(x), when it actually came from the foreground corpus, modeled
by p(x). The authors show that this metric has properties useful for key
phrase extraction, including prioritizing tokens whose frequency is high in
both the foreground and background.
Another popular technique, the C-value / NC-value method,
incorporates both a measurement of termhood and an analysis of context to
determine which sequences refer to terms [40]. The termhood of a phrase is
taken to be the frequency of occurrence, minus the frequency as a substring
within other terms. The final designation as a term also incorporates an
analysis of the context, where potential terms are used to find context words
that are likely triggers and these are then used to reinforce the final values
for termhood for each term. The authors note that this statistical technique
requires reevaluation by domain experts and filtering. This technique has
73
been employed in a biomedical context, and the idea of also taking advantage
of the context where terms appear will also be employed by us  using a
different method  in the next chapter.
7.1.1 Survey of language modeling
Language modeling estimates the probability of observing a specified
sequence of tokens, usually a sentence. Language modeling has found uses in
many well-established natural language processing tasks, particularly
machine translation [106], though it is also finding use in new research areas,
such as weakly-supervised techniques [57] and active learning [33]. A strong
advantage of language models is that they do not require labeled training
data. Rather, the only requirement is for a large quantity of the text to be
modeled, a condition satisfied in biomedical text through MEDLINE
abstracts and the PubMed open access subset of full-text articles.
One of the most common techniques for creating a language model is
n-grams. An n-gram model predicts the next token in a sequence, given n-1
previous tokens [77]. For example, n=3 in a trigram model, and the model
uses the previous 2 tokens to predict the following token. These probabilities
can be chained to calculate the probability of an arbitrarily long sequence.
This is often done in log space so as to prevent underflow.
A fundamental problem in language modeling is that there are valid
sequences which will not be observed in the training data; that is, the
training data is sparse. A straightforward application of maximum likelihood
estimation will result in a zero probability for all sequences not seen
previously. This is typically corrected through smoothing, which increases
the probability of unseen items slightly by reducing the probability of
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sequences observed. A simple illustrative example is Laplace smoothing, also
called add-one smoothing, because all counts are considered to be one higher
than the count observed. This results in the probability of a sequence never
being zero, but also results in most of the probability mass in the
distribution being reserved for unseen tokens, which may not be desirable
[77]. Many other techniques have been studied, including linear
interpolation, Good-Turing discounting, and Katz Backoff [17].
Building a wide-coverage n-gram model requires the storage of billions
of individual counts. To reduce the space requirements, language models
frequently employ a probabilistic data structure called a Bloom filter [10].
Bloom filters allow a space efficient way to store counts such that any errors
are one-way. That is, the structure may return a count higher than it should
be (false positive), but never a count that is lower (false negative). Recent
work employing Bloom filters in language models use a log-scale version as a
drop-in replacement for the filter with exact counts, resulting in significant
additional space savings [106, 107].
Other techniques for language modeling use maximum entropy
modeling [95], or model the entire sequence as a single instance [96]. Recent
work in language modeling explores many possible improvements, including
incorporating syntactic information [16], exploiting knowledge of the topic of
the document [108], and using a vector space of word similarity to reduce the
data sparsity problem [7]. Several studies performing empirical evaluations
demonstrate consistently strong results with a trigram model using
interpolated Kneser-Ney smoothing [17, 43], and ignoring words that occur
only once, also known as hapax legomena [120].
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7.2 Methods
Machine-learning based NER systems have frequently attempted to use
features incorporating additional domain knowledge. Lists of entity names,
frequently called dictionaries, are a domain resource that is not available for
all entity types of interest, due to the expense of creating and maintaining
the resource. When a list of entity names is available, however, there is a
strong desire to make use of the resource. Some early attempts to
incorporate dictionaries into biomedical NER systems resulted in reduced
performance, however [100]. Previous work showed a small improvement in
the performance after adding a name list consisting of single tokens filtered
to only contain names highly indicative of an entity name [50].
This chapter describes a method to describe the degree to which a
token sequence resembles an entity name. The degree to which a sequence
resembles an entity name is determined by taking the difference between two
language models, resulting in a real-valued feature. To do this a language
modeling approach designed for keyphrase extraction is adapted that models
the informativeness of a term as the loss between two language models: one
language model for the domain or application and one that is general. The
main idea of this technique is that language modeling allows us to create a
model to predict the likelihood of an arbitrary string. In this experiment,
however, two models are employed: a foreground model representing the sorts
of sequences which should be located and a background model that reflects
the sequences which should be ignored. Intuitively, the difference between
the probability estimates of these two models reflects the likelihood that the
given sequence comes from either the foreground or background model.
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System (Variant) Corpus Precision Recall F-measure
BANNER, order 1 NCBI Disease 0.820 0.784 0.802
With the feature NCBI Disease 0.810 0.780 0.794
BANNER, order 1 BioCreative 2 GM 0.860 0.834 0.847
With the feature BioCreative 2 GM 0.869 0.830 0.849
Table 7.1: NER evaluation results for the method of characterizing sequences
with language modeling, across two corpora.
In this application, a domain lexicon is employed as the foreground
text and MEDLINE, a large unlabeled corpus of biomedical abstracts, as the
background text. The likelihood of a token sequence referring to a entity is
defined as the pointwise Kullback-Leibler divergence between the probability
of the sequence according to the language model for the lexicon and the
probability according to the language model for the large unlabeled
biomedical corpus. The MEDIC disease lexicon is used for diseases [27],
while EntrezGene is used for genes and proteins [86]. Both the unsmoothed
language models and Laplace-smoothed language models are used. Also, both
the relative frequency ratio and the pointwise KL divergence are considered.
7.3 Results
This technique was evaluated using the BioCreative 2 Gene Mention data and
the NCBI Disease Corpus, as described in Table 7.1. Because the MEDIC
lexicon is relatively small, the creation of a unigram model is described.
Higher order models were attempted, however they were not successful.
7.4 Discussion
Given that modern language modeling techniques employ corpora with
millions or even billions of tokens, it was considered likely that domain
lexicons would be too sparse to learn an effective language model, since they
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contain thousands of tokens. This was not the case, however. Domain
lexicons are intended to be relatively complete for the entity described,
implying that much of the vocabulary needed to recognize entities of that
type will be present, even if many specific term variants are not. Moreover,
should it become necessary to deal with the sparseness in ways other than
smoothing, it is possible to use models of approximate word meaning rather
than probability of word appearance [7].
A more pressing concern is the fact that the meaning of the token
being frequent in the lexicon is not the same as the meaning of a token being
frequent in natural language text. With diseases, the technique is strong for
locating words that are frequently used to describe diseases, but not as strong
at locating the head word itself. For example, in the phrase autosomal
recessive disease, both autosomal and recessive are given a relatively
high score, while disease is given a relatively low score. This occurs because
even though the word disease appears frequently in the foreground corpus,
the lexicon, it also appears frequently in the background corpus, MEDLINE,
decreasing the difference between their distributions. Many other disease
names have similar issues. An excellent example is the word tumor, which
often refers to a disease but is also frequently used in expressions describing
other related concepts, such as tumor suppressor. The method was not
observed to prefer either heads or descriptive words for genes and proteins.
This technique has several significant advantages. First, while it does
require the use of a lexicon, these are often available. More importantly, this
technique is unsupervised and therefore does not require training data.
Second, while state-of-the-art systems employing language modeling require
significant resources due to the use of very large corpora or long n-grams
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[107], the use of language models requires several orders of magnitude fewer
resources. This technique is therefore very lightweight. Moreover, the
advanced techniques described in the literature to enable high performance
from the much larger language models can also be employed here. Third,
because there has been significant research into techniques to improve
language models, there is a significant amount of existing literature that can
be explored in an attempt to improve this technique.
7.5 Conclusion
A novel method for named entity recognition has been proposed by
repurposing techniques used in language modeling and term recognition.
While this approach was not able to demonstrate a performance
improvement, variations of this technique may deserve further study.
Future named entity recognition studies employing this technique
would likely benefit from using multiple instances to model many lexicons
simultaneously. This would be useful because it would allow the machine
learning model to determine whether a the resemblance to another entity
type increases or decreases the likelihood that it refers to the type of interest.
This approach may be useful for studies with only a small amount of training
data. In an active learning approach this technique would provide fast initial
improvements to the system by allowing it to concentrate primarily on the
differences between the way the mentions are represented in the lexicon and
the way they are used in text, rather than needing to learn both from the
beginning. Finally, it would be interesting to evaluate expanding this
technique to other comparisons besides a lexicon as a foreground corpus and
a domain text is a background corpus. For example, it would be expected
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that biomedical entities should appear in a domain corpus, such as
MEDLINE, more frequently than in a nonspecific English corpus like
newswire.
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Chapter 8
CHARACTERIZING SEQUENCES WITH DISTRIBUTIONAL
SEMANTICS
The rich feature set approach is characterized by employing a large number
of features, each of which contains a relatively small amount of information.
This chapter describes a method to improve the feature set by introducing a
new technique for named entity recognition based on distributional semantics
and employing it as a feature. A form of the distributional semantics
hypothesis is employed, namely that it is possible to approximate the
meaning of a word by observing the contexts in which it appears. Such
techniques are advantageous for NER since they can partially compensate for
the finite size of the training data, and have proved popular in recent work
[61, 115]. Unlike previous work in distributional semantics, however, the
method proposed models the meaning of token sequences as a unit rather
than modeling the meaning of individual tokens. This is important since
entity names exhibit meanings that are non-compositional, meaning that
they cannot be accurately predicted from the sum of the meaning of their
constituent tokens [77]. MEDLINE abstracts are used as the unlabeled text,
since biomedical abstracts often contain statements defining the entities in
the discourse.
8.1 Related work
Distributional semantics approaches have been used successfully to improve
performance of named entity recognition systems by improving the
representation of existing features or introducing new ones [61, 115].
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Distributional semantics is based on the distributional hypothesis, which
states that the meaning of a word can be inferred from the contexts in which
it appears [52, 54]. The idea was famously summarized by Firth as you shall
know a word by the company it keeps [38]. Distributional semantics is
therefore the creation of quantitative models of word meaning through
analyzing the contexts where words are found [21].
Distributional semantics techniques can be broadly characterized as
either probabilistic or geometric. Probabilistic models of distributional
semantics treat texts as a mixture of several topics so that the probability
that a word appears can be modeled as the combination of the probability of
each topic. Geometric models represent words as vectors in a
high-dimensional space created as a representation of the contexts where
words appear. Another important property of distributional semantic models
is the type of relationships represented [29]. A syntagmatic relationship is
the type of relationship between words that tend to co-occur, such as
between a gene name and the disease caused by a variant of the gene, or
perhaps a protein and its subcellular localization. A paradigmatic
relationship is between words that can substitute for the other without
modifying the syntactic structure of the sentence, such as between the names
of different genes.
A significant advantage of distributional semantics is that it does not
require expensive labeled data, only a relatively large amount of unlabeled
text. There are many words which do not appear frequently enough in the
training data to gain a sense of their meaning, but do appear frequently
enough in a large unlabeled text to approximate their meaning with
distributional semantics. Existing approaches in distributional semantics
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model the meaning of single tokens, even though the names of many
biomedical entities span multiple tokens.
8.2 Methods
In preliminary experiments, it was determined that the context surrounding
mentions of both genes and diseases exhibits distinctive variations from the
remainder of the text. Dunning's likelihood ratio is used to determine which
tokens appear significantly more often in the context either to the left or to
the right of an entity mention more frequently than would be expected by
chance. Many thousands of tokens were found to appear more frequently
than would be expected by chance when all mentions of a specified type were
considered as a single group. However, when each mention individually was
considered individually, it was rare to find any tokens which appear
significantly more frequently than would be expected by chance. This is
primarily because the frequency of each individual mention is so low.
While these results are not unexpected, it would be beneficial to find
some tokens appear more frequently than would be expected by chance
around many mentions, thereby giving high confidence that these tokens are
highly indicative of entities of that type. It was therefore determined instead
to select the tokens that appear most frequently when mentions are
considered as a single group. It was decided to follow prior work and employ
K nearest neighbors.
The method for using unlabeled data to create features for biomedical
NER proceeds as follows. For each mention in the labeled data, all instances
of the same sequence of tokens in the unlabeled data were located. For each
instance of the same sequence of tokens, the context to the left and the right
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of the mention were extracted, and the frequency of each token found tallied.
Once all mentions were processed, the counts of each token were compared
with the count expected by chance, based on the number of times the token
appears in the corpus.
To summarize the method, labeled token sequences from the training
data are represented as vectors created from the context surrounding other
instances of that sequence in a large amount of unlabeled data. Rather than
model the context on both sides simultaneously, one model is created for the
right side and another model for the left. The likelihood that any given
unlabeled token sequence refers to a mention can then be determined by
converting it into right and left context vectors, applying the K nearest
neighbor algorithm to classify each, and then combining the result.
The initial step is preprocessing the text. Because this method is
based on locating other instances of term surface forms, the main
considerations for ensuring adequate performance are to reduce ambiguity
and variation. The unlabeled text is broken into sentences using the Java
sentence breaker, which was adapted to not break sentences within
parentheses. Punctuation and stopwords are both dropped. Tokens are
stemmed and numbers are normalized to the single digit zero, to improve
handling of variation in surface forms. All abbreviations in the training and
test data are resolved using the Schwartz and Hearst algorithm, to reduce
the ambiguity of the terms [99].
Some tokens appearing in the context surrounding a potential mention
may be significantly more useful for discriminating between mentions and
non-mentions. Feature selection is therefore employed to limit the tokens
used for inference to a relatively small set of the most useful. Dunning's
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likelihood ratio test for collocations was adapted to find words appearing
more frequently than chance surrounding token sequences [77]. Two feature
sets are created, one for the context to the left of the potential mention, and
one for the context to the right. All instances of the token sequences labeled
as mentions in the training data are then located in the unlabeled data set .
Next, the number of times each token appears in the context of a specified
size surrounding the other instances is counted. These frequencies are
compared with the frequency that each token appears in the corpus as a
whole using Dunning's likelihood ratio. This statistic allows us to determine
the number of times the token appears more frequently than chance, and is
known to be more accurate at low counts than Pearson's Chi-squared test
[91]. A threshold is set manually and select all tokens that are more likely to
appear in the context surrounding a mention than the threshold.
Two separate context vector models are then created, one for the
context to the left of the sequence and the other representing the context to
the right. Both models use an order-independent bag of words to represent
individual tokens found within a window of specified size. The vectors are
therefore very high dimensional (over one million), but also very sparse,
typically containing less than a few hundred nonzero dimensions. The
TF-IDF representation is used, where the TF is defined as the number of
contexts where the token appears, and IDF is the log of the number of times
the token appears in the entire unlabeled corpus. This representation reflects
both the importance of the context token for the token sequence and also the
relative importance of the context token in the corpus of the whole. All
vectors are normalized to unit length to compensate for the wide variation in
the frequency of each token sequence.
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Each model is then loaded with labeled vectors using sequences from
the training data. One vector is created for each mention in the training
data. Vectors are also created for each token sequence up to the specified
maximum mention length that is not part of a mention. While many
approaches to terminology extraction use a white-list approach to
determining which sequences are worth considering, this experiement used a
black-list approach with only two rules, ignoring only sequences that are very
unlikely to represent a mention. The first rule stipulates that the sequence
may not begin or end with a word that is a member of a closed syntactic
class in English, such as determiners. The second rule states that the
sequence may not contain a comma. This rule was adopted empirically, to
increase precision, since commas are valid in mentions involving coordination.
Because token sequences may appear many times in the training data, the
vectors were labeled with both the number of times that the token sequence
represented appears as a mention in the training data, and also the number
of times that the token sequence appears as a non-mention. Note that tokens
in the training data that are not part of a mention will be used to create
many vectors from overlapping n-grams, but each mention is only
represented once, as a complete unit. Note also there are no vectors spanning
the boundary between mention and non-mention text.
Arbitrary unlabeled token sequences can then be classified by using
the large unlabeled corpus to convert it to a context vector and using k
nearest neighbors with the labeled vectors from the training data. Standard
cosine similarity is used as the similarity metric. Since each training data
vector is annotated with the number of times its origin token sequence is
labeled as a mention or as non-mention text, several methods were
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considered to convert these counts into an overall summary value between
zero and one. The conversion that was found to best differentiate between
the sequences representing mentions and non-mentions is the average of the
probability that each vector would be labeled as a mention, weighted by
similarity. This score is considered to be the likelihood that the n-gram
represents a mention. The likelihood from both the left and right models is
obtained and converted to a joint likelihood by multiplying the two.
Given a sentence, the most likely segmentation for the sentence must
be found. This can be determined using a greedy approach. The likelihood
that each subsequence in the sentence refers to a mention according to the
left and right models is determined. the sequences considered are limited in a
manner similar to the training data, namely, sequences that either begin or
end with tokens that are a member of a closed syntactic class, or that
contain a comma, are not considered. The sequences are sorted in order of
decreasing likelihood and consider each for selection in that order. Sequences
that overlap with a previously selected sequence but do not contain it are
removed. The result is a set of likely mentions, with some mentions (e.g.
male breast cancer) containing other likely mentions (breast cancer). All
mentions above a predefined threshold are accepted and returned to the next
processing unit. Alternatively, the highest score for each token in the
sentence may be calculated and passed as features to a named entity
recognizer such as BANNER.
8.3 Results
This technique was evaluated using the BioCreative 2 Gene Mention data and
the NCBI Disease Corpus as training and test data. MEDLINE was used as
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Genes and Proteins
Left Right
express cell
cd0 express
activ active
serum gene
alpha receptor
beta protein
a alpha
c inhibitor
anti level
human ml
degre respect
protein mrna
Diseases
Left Right
breast cell
human patient
patient mellitu
prostat line
primari viru
malign necrosi
lung a
cell plyori
colorect associ
doubl cancer
type suppressor
acut factor
Table 8.1: List of stemmed tokens selected from those most strongly associated
with appearing to the left or to the right of either genes or diseases.
the unlabeled corpus. The context window was set to 3 tokens. The feature
selection only considered tokens that are 100 times more likely to appear in
the context surrounding a disease mention than to appear in general.
These settings resulted in 9,754 tokens in the left context feature set
and 10,252 tokens for the right context feature set. The stemmed tokens
associated most strongly with appearing in the context of gene names and
disease names, to both the left and the right, can be seen in Table 8.1. To
reduce the search space, the maximum mention length was set to 6 tokens,
resulting in the extraction of 276,473 labeled sequences from the training set.
The number of nearest neighbors considered for the K nearest neighbors
algorithm was set to 20.
The results of incorporating the method of characterizing sequences
with distributional semantics as a feature into the BANNER named entity
recognizer are described in Table 8.2. Both precision and recall increase by
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System (Variant) Corpus Precision Recall F-measure
BANNER, order 1 NCBI Disease 0.820 0.784 0.802
With the feature NCBI Disease 0.831 0.795 0.813
BANNER, order 1 BioCreative 2 GM 0.860 0.834 0.847
With the feature BioCreative 2 GM 0.878 0.847 0.862
Table 8.2: NER evaluation results for the method of characterizing sequences
with distributional semantics, across two corpora.
over 1.0% across both corpora. F-measure increases by 1.1% for diseases and
1.5% for genes. We performed an additional round of evaluation, limiting the
base feature set to the features selected by joint mutual information with
false discovery rate control. The results of this experiment are described in
Table 8.3. We note that the addition of the feature characterizing sequences
with distributional semantics results in significant performance increases,
though the performance is not yet approaching the level of the full feature
set.
8.4 Discussion
The first observation is that this method is adept at finding the head words
of a mention, but not quite as strong at finding the mention boundaries.
This is likely because the head words appear more frequently in MEDLINE
and in more discriminative contexts. The score assigned to unlabeled context
vectors according to the algorithm appears to decay exponentially rather
than linearly. This is also not unexpected, given the high number of
dimensions and the fact that the quality of the context vectors goes down as
the frequency of the n-gram used to create it drops exponentially according
to Zipf's law.
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System (Variant) Corpus Precision Recall F-measure
BANNER, using
only the features
selected by JMI
NCBI Disease 0.701 0.617 0.656
BANNER, using
the features se-
lected by JMI and
the distributional
semantics feature
NCBI Disease 0.741 0.647 0.691
BANNER, us-
ing only features
selected by JMI
BioCreative 2 GM 0.635 0.408 0.496
BANNER, using
only features se-
lected by JMI and
the distributional
semantics feature
BioCreative 2 GM 0.778 0.616 0.687
Table 8.3: NER evaluation results for the method of characterizing sequences
with distributional semantics, across two corpora, using only the features se-
lected by joint mutual information with FDR control.
8.4.1 Limitations
The most significant limitation of this technique is the processing time
required to create and classify the context vectors. Tt required nearly one
hour to create the context vectors for 100 PubMed abstracts. The amount of
time required for classifying the vectors, however, varies significantly with
the number of vectors created and also the number of tokens used as features
in the context. Reducing the n-grams considered to lengths no longer than 6
and that do not begin or end with words from closed classes in English
significantly reduced the number of n-grams considered, and was necessary to
make the problem tractable. This technique may be employed in the future
in conjunction with a technique that analyzes the content of the potential
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mentions to determine which sequences are likely to contain entities of the
specified type, thereby reducing the number of vectors that must be
compared. This study will motivate additional research to find more
computationally efficient ways to achieve similar results.
Another issue with this technique is that there is no ability to
deemphasize a head found as part of a multi-word phrase that should be
ignored. For example, the word tumor from tumor suppressor will
initially receive the same score as tumor from pancreatic tumor. This is
partially corrected when the greedy method for filtering the sequences
extends to tumor from pancreatic tumor the score from pancreatic
tumor, which should be much higher than tumor alone.
Next, this technique assumes that the meaning of sequences is fairly
fixed throughout the literature. That is, the same sequence of tokens has the
same meaning everywhere. This assumption is unfortunately not the case
either in general or with entity names, however it is a closer approximation
with entity names.
The length limitation is a limitation in two ways. First, the
probability of a sequence being a sufficiently fixed phrase that it appears
multiple times in the unlabeled corpus goes down significantly as the length
increases. Second, the number of sequences to consider from the training
data goes up exponentially in the length of the sequence. It is possible that
this problem can be worked around by considering sequences of all lengths in
a sentence but only using the first tokens on the left or last tokens on the
right if a sequence is over a predetermined length. Evaluation of this
potential improvement is left as future work.
91
8.5 Conclusion
Distributional semantics has been demonstrated to be a viable technique for
improving named entity recognition when the compositionality of the
mentions is considered. Moreover, the strong performance of this technique
suggests that it may be viable, with additional work, alongside the
conditional random fields approach rather than only as an additional feature.
To accomplish the goal of making this useful in the future, the
primary limitation is the significant computational resources required for
classifying each context vector. There are methods, however, which may
increase the performance of this technique considerably. For example, while
support vector machines and logistic regression require some time to train,
they perform inference much faster than K nearest neighbor. They would
therefore be strongly preferable, provided that a method such as cross
validation is used to ensure that the sequence classification model trained on
their output does not overfit. Moreover, if K nearest neighbors is retained, it
would be useful to employ a dimensionality reduction technique such as
latent semantic indexing or random indexing, both of which create much
smaller vectors [21, 97].
The results of the right and left models would be ideal for
incorporating as features in a semi-Markov conditional random fields system
[98]. In semi-Markov conditional random fields, features may be defined
against sequences, in addition to individual tokens. This would allow the
output of the context vector classifier to be used directly as a feature in a
semi-Markov conditional random fields model, bypassing the greedy sequence
analysis algorithm employed.
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This method may be extended to find indicative token sequences in
the context rather than single tokens. It would be expected to find, for
example, that transcription factor and tumor suppressor are both highly
correlated with a protein mention. Augmenting the selection of highly
indicative features with false discovery rate analysis using the probes
technique, as described in the survey of feature selection, may be useful
determining when to stop adding new features.
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Chapter 9
CONCLUSION
The proposed techniques and evaluation have demonstrated the size of the
performance improvements possible through improving the feature set
through adding new features based on counts from unlabeled text and
feature selection.
Biomedical named entity recognition using conditional random fields
and the rich feature set approach has been very successful. These techniques
have allowed named entity recognition performance to approach human level,
and has reduced the effort required for creating a named entity recognition
system for a new domain considerably. While this success is a welcome
development, research in named entity recognition has concentrated
primarily on this approach, neglecting other forms of information extraction
and natural language processing. In a sense, this dissertation is an attempt
to re-envision named entity recognition not as a nearly-solved problem
employing highly specialized techniques, but rather demonstrate how
advances in other areas of NLP can be profitably adapted and employed in
named entity recognition.
9.1 Conclusions
In conclusion, it is very difficult to improve on conditional random fields with
the rich feature set approach. While some of the features generated this way
may not be stable, the feature set generated is of sufficient quality that there
are as yet no known methods to improve on the set with feature selection.
The techniques for modeling the content of potential mentions using lexicons
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and language modeling was marginally successful, and may be worth
revisiting going forward. However the technique for using distributional
semantics to model the meaning of a potential mention was significantly
successful, and with performance improvements, may become a standard
part of named entity recognition systems such as BANNER.
9.2 Summary of Advances
Methods for improving the performance of biomedical named entity
recognition (NER) systems have been considered. The fact that biomedical
NER is an important real world problem with significant remaining
difficulties has been noted. The state-of-the-art techniques for biomedical
NER have been surveyed, including the rich feature set approach, and argued
that this approach is subject to diminishing returns. Improving the feature
set employed with two complementary approaches has therefore been
proposed. In the first approach, two new feature templates for modeling the
semantics of a token sequence, one template modeling context with
distributional semantics, and the other modeling content with language
modeling. In addition, two novel variations on feature selection techniques,
with improvements for the specific needs of biomedical NER. These
techniques consider overlapping and interacting features, can be used in
environments with extremely high skew, and limit the number of irrelevant
features admitted via false discovery rate control.
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